<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Complement Altern Med</journal-id><journal-id journal-id-type="iso-abbrev">BMC Complement Altern Med</journal-id><journal-title-group><journal-title>BMC Complementary and Alternative Medicine</journal-title></journal-title-group><issn pub-type="epub">1472-6882</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30497462</article-id><article-id pub-id-type="pmc">6267063</article-id><article-id pub-id-type="publisher-id">2377</article-id><article-id pub-id-type="doi">10.1186/s12906-018-2377-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Utilization of Chinese medicine for respiratory discomforts by patients with a medical history of tuberculosis in Taiwan</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Yang</surname><given-names>Su-Tso</given-names></name><address><phone>+886-4-22052121</phone><email>yangst@mail.cmu.edu.tw</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Yi-Rong</given-names></name><address><email>u102043001@cmu.edu.tw</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Mei-Yao</given-names></name><address><email>meiyaowu0919@gmail.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Chiang</surname><given-names>Jen-Huai</given-names></name><address><email>zinvii@gmail.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Pei-Shan</given-names></name><address><email>s832845@gmail.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hsia</surname><given-names>Te-Chun</given-names></name><address><email>derrick.hsia@msa.hinet.net</email></address><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0131-1658</contrib-id><name><surname>Yen</surname><given-names>Hung-Rong</given-names></name><address><phone>+886-4-22053366 ext 3005</phone><email>hungrongyen@gmail.com</email><email>hungrongyen@mail.cmu.edu.tw</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref><xref ref-type="aff" rid="Aff10">10</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0083 6092</institution-id><institution-id institution-id-type="GRID">grid.254145.3</institution-id><institution>Graduate Institute of Chinese Medicine, </institution><institution>School of Chinese Medicine, College of Chinese Medicine, China Medical University, </institution></institution-wrap>Taichung, Taiwan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0572 9415</institution-id><institution-id institution-id-type="GRID">grid.411508.9</institution-id><institution>Department of Radiology, </institution><institution>China Medical University Hospital, </institution></institution-wrap>Taichung, Taiwan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0572 9415</institution-id><institution-id institution-id-type="GRID">grid.411508.9</institution-id><institution>Department of Chinese Medicine, </institution><institution>China Medical University Hospital, </institution></institution-wrap>Taichung, Taiwan </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0572 9415</institution-id><institution-id institution-id-type="GRID">grid.411508.9</institution-id><institution>Management Office for Health Data, China Medical University Hospital, </institution></institution-wrap>Taichung, Taiwan </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0083 6092</institution-id><institution-id institution-id-type="GRID">grid.254145.3</institution-id><institution>Department of Respiratory Therapy, </institution><institution>China Medical University, </institution></institution-wrap>Taichung, Taiwan </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0572 9415</institution-id><institution-id institution-id-type="GRID">grid.411508.9</institution-id><institution>Department of Internal Medicine, </institution><institution>China Medical University Hospital, </institution></institution-wrap>Taichung, Taiwan </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0572 9415</institution-id><institution-id institution-id-type="GRID">grid.411508.9</institution-id><institution>Research Center for Traditional Chinese Medicine, Department of Medical Research, </institution><institution>China Medical University Hospital, </institution></institution-wrap>Taichung, Taiwan </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0083 6092</institution-id><institution-id institution-id-type="GRID">grid.254145.3</institution-id><institution>Research Center for Chinese Herbal Medicine, </institution><institution>China Medical University, </institution></institution-wrap>Taichung, Taiwan </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0083 6092</institution-id><institution-id institution-id-type="GRID">grid.254145.3</institution-id><institution>Chinese Medicine Research Center, China Medical University, </institution></institution-wrap>Taichung, Taiwan </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9263 9645</institution-id><institution-id institution-id-type="GRID">grid.252470.6</institution-id><institution>Department of Biotechnology, </institution><institution>Asia University, </institution></institution-wrap>Taichung, Taiwan </aff></contrib-group><pub-date pub-type="epub"><day>29</day><month>11</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>29</day><month>11</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>18</volume><elocation-id>313</elocation-id><history><date date-type="received"><day>31</day><month>3</month><year>2018</year></date><date date-type="accepted"><day>15</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Tuberculosis (TB) is one of the world&#x02019;s major communicable infectious diseases, and it still imposes a great health burden in developing countries. The development of drug-resistant TB during the treatment increases the treatment complexity, and the long-term pulmonary complications after completing treatment raise the epidemic health burden. This study intended to investigate the utilization of Chinese medicine (CM) for respiratory symptoms by patients with a medical history of TB in Taiwan.</p></sec><sec><title>Methods</title><p id="Par2">We analyzed a cohort of one million individuals who were randomly selected from the National Health Insurance Research Database in Taiwan. The inclusion criteria of patients (<italic>n</italic>&#x02009;=&#x02009;7905) with history of TB (ICD-9-CM codes 010&#x02013;018 and A02) were: (1) TB diagnosed between January 1, 1997 and December 31, 2010 (2) 18&#x02009;years old or over (3) Clinical records for at least 2&#x02009;months with complete demographic information (4) Record of treatment with first-line TB medication prescriptions. CM users for conditions other than respiratory discomforts (<italic>n</italic>&#x02009;=&#x02009;3980) were excluded. Finally, a total of 3925&#x02009;TB patients were categorized as: CM users for respiratory discomforts (<italic>n</italic>&#x02009;=&#x02009;2051) and non-CM users (<italic>n</italic>&#x02009;=&#x02009;1874).</p></sec><sec><title>Results</title><p id="Par3">Among the 3925 subjects, 2051 (52.25%) were CM users, and 1874 (44.753%) were non-CM users. Female patients and those who were younger (18&#x02013;39 y/o) and who lived in urbanized areas relatively tended to be CM users (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.0001). Most of the CM users (1944, 94.78%) received Chinese medicines. The most commonly prescribed herbal formulas and single herbs were Xiao-Qing-Long-Tang and Radix Platycodonis (Jie-Geng), respectively. The core pattern of Chinese medicines for TB patients consisted of Ma-Xing-Gan-Shi-Tang, Bulbus Fritillariae Thunbergii (Bei-Mu), Radix Platycodonis (Jie-Geng) and Semen Armeniacae (Xing-Ren).</p></sec><sec><title>Conclusions</title><p id="Par4">The use of CM is popular among patients with a medical history of TB complicated with long-term respiratory discomforts in Taiwan. Further pharmacological investigations and clinical trials are required.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Chinese medicine</kwd><kwd>National Health Insurance Research Database</kwd><kwd>Prescription</kwd><kwd>Respiratory diseases</kwd><kwd>Tuberculosis</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010002</institution-id><institution>Ministry of Education</institution></institution-wrap></funding-source><award-id>Chinese Medicine Research Center, China Medical University, under the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project</award-id><principal-award-recipient><name><surname>Yen</surname><given-names>Hung-Rong</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008903</institution-id><institution>Ministry of Health and Welfare</institution></institution-wrap></funding-source><award-id>MOHW107-TDU-B-212-123004</award-id><award-id>MOHW107-TDU-B-212-114024</award-id><principal-award-recipient><name><surname>Yen</surname><given-names>Hung-Rong</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004391</institution-id><institution>China Medical University Hospital</institution></institution-wrap></funding-source><award-id>DMR-106-183</award-id><principal-award-recipient><name><surname>Yen</surname><given-names>Hung-Rong</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par10">In the twenty-first century, tuberculosis (TB) continues to be one of the world&#x02019;s major health challenges. TB is a deadly communicable disease that is primarily transmitted from human to human by droplet infection, and it is a major health burden in both developed and developing countries. Approximately 9.0 million people developed TB, and 1.5 million died from the disease in 2013 [<xref ref-type="bibr" rid="CR1">1</xref>]. Of the 9.0 million estimated cases, 56% were in Southeast Asian and Western Pacific regions [<xref ref-type="bibr" rid="CR2">2</xref>]. China accounted for 11% of the 9.0 million estimated TB cases, and 11,528&#x02009;TB cases were confirmed in Taiwan [<xref ref-type="bibr" rid="CR3">3</xref>]. Male, elderly and immunocompromised patients, including those with HIV, patients with poorly controlled diabetes mellitus or chronic kidney disease or those receiving immunosuppressant treatments, are generally more susceptible to the disease [<xref ref-type="bibr" rid="CR4">4</xref>]. Healthcare workers who are exposed to TB also have higher risks of being infected [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par11">Due to the side effects of the drugs [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>], poor medication compliance and the problem of development of drug-resistant TB, global investment in TB research is needed [<xref ref-type="bibr" rid="CR8">8</xref>]. Among the first-line anti-TB drugs, side effects of hepatotoxicity have been reported to be associated with isoniazid, rifampin and pyrazinamide; cutaneous reactions with isoniazid, pyrazinamide and ethambutol; gastrointestinal intolerance with rifampin; retrobulbar neuritis with ethambutol; and ototoxicity with streptomycin [<xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref>]. Long-term respiratory symptoms and impairment of pulmonary function affect patients&#x02019; quality of life after completing TB treatment. The respiratory comorbidities were identified in more than half of microbiologically cured TB patients [<xref ref-type="bibr" rid="CR12">12</xref>]. Despite successful treatment of TB, residual impairments persist, and chronic complications or sequelaes can arise from structural or vascular alterations at disease sites [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Many patients with chronic illness may seek complementary therapies [<xref ref-type="bibr" rid="CR15">15</xref>], especially Chinese Medicine (CM) in Asian countries [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. CM, which originated in ancient China, is defined as comprehensive healthcare skills and practice for the maintenance of health and treatment of disease based on the beliefs of holism [<xref ref-type="bibr" rid="CR18">18</xref>] and experiences of pattern identification/syndrome differentiation handed down from generation to generation [<xref ref-type="bibr" rid="CR19">19</xref>]. In Taiwan, CM is important and popular among different categories of complementary therapies, and is regarded as one of the mainstream therapies with coverage of the National Health Insurance (NHI) program [<xref ref-type="bibr" rid="CR17">17</xref>]. &#x0201c;CM&#x0201d; usually refers to the overall treatment modalities, and services of CM covered by the NHI program, which includes Chinese medicines, acupuncture, moxibustion and Chinese traumatology therapy [<xref ref-type="bibr" rid="CR20">20</xref>]. &#x0201c;Chinese medicines&#x0201d; usually refers to herbs or herbal products which can be classified into single-herb products and herbal formulas (multi-herb products) [<xref ref-type="bibr" rid="CR21">21</xref>]. In Taiwan, herbal products (concentrated scientific herbal granules) covered by the NHI program are manufactured by GMP-certified pharmaceutical companies [<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par12">The ancient CM literature did not use the word &#x0201c;TB&#x0201d;, but rather considered this pulmonary condition to be related to a syndrome of lung consumption characterized by cough, hemoptysis, tidal fever, night sweats and emaciation due to consumptive or exhaustive overstrain. It was reported that Chinese medicines combined with conventional medicine has beneficial effects for inhibiting Mycobacterium, strengthening the immune system of the body, enhancing the effect of anti-TB drugs, reducing drug resistance, and being relatively safe [<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>]. While several studies have investigated the use of CM in the care of TB patients [<xref ref-type="bibr" rid="CR23">23</xref>], there is a lack of this kind of survey on the use of CM among patients with a medical history of TB and complicated with long-term respiratory discomforts.</p><p id="Par13">We intended to investigate the utilization of CM among patients with a medical history of TB complicated with long-term respiratory discomforts in this study. The results of this study will be useful for future clinical trials and pharmacological investigations regarding efficacy and safety.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Data sources</title><p id="Par14">The NHI program was established in Taiwan in 1995. The program was highly representative of samples of Taiwan&#x02019;s general population because the reimbursement policy is universal and mandatory. The coverage rate of this compulsory health insurance program reached almost 95% in 1997 [<xref ref-type="bibr" rid="CR26">26</xref>] and 99.4% at the end of 2010 in Taiwan [<xref ref-type="bibr" rid="CR27">27</xref>]. CM services that are reimbursed in the NHI program include Chinese medicines, acupuncture, moxibustion, and Chinese traumatology therapy [<xref ref-type="bibr" rid="CR28">28</xref>]. The National Health Insurance Administration provided the registration files and original claims data to the National Health Research Institutes, which established and managed the National Health Insurance Research Database (NHIRD) for research purposes. This study was based in part on data from the NHIRD. It contains data comprising demographic characteristics, medical care facilities, outpatient and inpatient visits, visit dates, diagnostic codes, management, prescriptions and medical expenditures. We acquired a randomly selected sample consisting of one million individuals (Longitudinal Health Insurance Database 2000; LHID 2000) from the NHIRD managed and released by the National Health Research Institutes, Taiwan. The diagnostic codes were from the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) formats.</p></sec><sec id="Sec4"><title>Ethical consideration</title><p id="Par15">This study followed the ethical standards of the responsible committee and with the Helsinki Declaration of 1964 and later versions. All the datasets were de-identified and encrypted before released by the National Health Research Institutes, Taiwan. All of the individuals or care providers could not be identified in the database. Patient consent was exempted for the total anonymity of all research data in this study. Therefore, the Research Ethics Committee of China Medical University and Hospital approved this study and waived the requirement for informed consent (CMUH104-REC2&#x02013;115).</p></sec><sec id="Sec5"><title>Study population</title><p id="Par16">Patients newly diagnosed with TB (ICD-9-CM codes 010&#x02013;018 and A02) (<italic>n</italic>&#x02009;=&#x02009;36,660) were selected from the database. To avoid the inclusion of patients who did not have the disease, we set the inclusion criteria to allow only patients who were newly diagnosed with TB from January 1, 1997, to December 31, 2010, with clinical records from at least 2&#x02009;months and treatment with first-line TB medication prescriptions (isoniazid, rifampin, pyrazinamide &#x00026; ethambutol) (<italic>n</italic>&#x02009;=&#x02009;8306). Because the prevalence and etiology of TB infections in children were different, and the medical services-seeking behaviors among children or adolescents were mainly dominated by their parents, children with TB infections were not included in our objectives. Therefore, we further excluded patients who were less than 18&#x02009;years of age or who had missing information related to birth and sex (<italic>n</italic>&#x02009;=&#x02009;401). A total of 7905&#x02009;TB patients were then included. Therefore the sample inclusion criteria is as following: (1) TB diagnosed between January 1, 1997 and December 31, 2010. (2) 18&#x02009;years old or over. (3) Clinical records for at least 2&#x02009;months with complete demographic information (4) Record of treatment with first-line TB medication prescriptions. CM users were defined as those who had visited CM clinics and had CM outpatient clinical records of TB or respiratory diseases (ICD-9-CM codes 786.x or 460&#x02013;519). Non-CM users were defined as those who never visited CM clinics after the initial diagnosis of TB. To investigate TB patients complicated with long- term respiratory discomforts, we further excluded those clinical visits with a non-TB or respiratory diagnosis (<italic>n</italic>&#x02009;=&#x02009;3980). Finally, a total of 3925&#x02009;TB patients were then categorized into CM users (<italic>n</italic>&#x02009;=&#x02009;2051) and non-CM users (<italic>n</italic>&#x02009;=&#x02009;1874) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Taiwan is a country with a population of 23 million. Taiwan has a geographical area of 36,000&#x02009;km<sup>2</sup>. There were 23 cities and 359 townships in Taiwan and many of its residents live within urban cities. The residential areas of 23 cities in Taiwan were classified into 4 levels of urbanization based on the population density (people/km<sup>2</sup>), the ratio of the population with varying educational levels, and the number of physicians per 100,000 people. Level 1 represents the highest urbanized level, while 4 represents the lowest level. Levels 1 and 2 of this urbanization were defined as urban areas, while levels 3 and 4 were classified as rural areas [<xref ref-type="bibr" rid="CR29">29</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>Recruitment flow chart of subjects with tuberculosis (TB) from one million randomly selected samples in the National Health Insurance Research Database (NHIRD) from 1997 to 2000 in Taiwan. The inclusion criteria of patients (<italic>n</italic>&#x02009;=&#x02009;7905) with history of TB (ICD-9-CM codes 010&#x02013;018 and A02) were: (1) TB diagnosed between January 1, 1997 and December 31, 2010 (2) 18&#x02009;years old or over (3) Clinical records for at least 2&#x02009;months with complete demographic information (4) Record of treatment with first-line TB medication prescriptions. CM users for conditions other than respiratory discomforts (<italic>n</italic>&#x02009;=&#x02009;3980) were excluded. Finally, a total of 3925&#x02009;TB patients were categorized as: CM users for respiratory discomforts (<italic>n</italic>&#x02009;=&#x02009;2051) and non-CM users (<italic>n</italic>&#x02009;=&#x02009;1874)</p></caption><graphic xlink:href="12906_2018_2377_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec6"><title>Prescription of Chinese medicines</title><p id="Par17">We listed the herbal formulas by their phonetic pin-yin name and single herbs by their phonetic pin-yin name, Chinese material medica name and plant name. Indications for the herbal formulas and single herbs were based on CM theory [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Full botanical names were in accordance with the International Plant Names List (IPNI; <ext-link ext-link-type="uri" xlink:href="http://www.ipni.org">http://www.ipni.org</ext-link>) and The Plant List (<ext-link ext-link-type="uri" xlink:href="http://www.theplantlist.org">http://www.theplantlist.org</ext-link>/) [<xref ref-type="bibr" rid="CR32">32</xref>]. An open-sourced freeware Node XL (<ext-link ext-link-type="uri" xlink:href="http://nodexl.codeplex.com">http://nodexl.codeplex.com</ext-link>/) was utilized to identify the core patterns of prescriptions for TB patients, and the most common co-prescribed Chinese medicines were demonstrated in this network analysis. As previously described [<xref ref-type="bibr" rid="CR33">33</xref>], the larger of the spots with thicker-line widths indicated significant prescription patterns and counts of close connections between formulas and herbs in the network figure.</p></sec><sec id="Sec7"><title>Statistical analysis</title><p id="Par18">All statistical analyses were performed using SAS software, version 9.4 (SAS Institute Inc., Cary, NC, USA). Univariate analysis was utilized to compare the CM users with the non-CM users. Data analysis comprised descriptive statistics, including the frequency of herbal prescriptions, patient demographic characteristics, indications for the TCM prescription, and the most frequently prescribed herbal formulas and herbs for treating TB. The chi-square test was used to examine the relationships between the categorical variables and to examine the differences between CM users and non-CM users. A <italic>P</italic>-value of &#x0003c;&#x02009;0.05 was considered statistically significant.</p></sec></sec><sec id="Sec8"><title>Results</title><p id="Par19">In this study, we identified 52.25% (<italic>n</italic>&#x02009;=&#x02009;2051) patients with a medical history of TB who had visited CM clinics and had CM outpatient clinical records of TB or respiratory diseases (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Those who were female, younger (18&#x02013;39 y/o), and lived in higher urbanized areas (levels 1 and 2) were relatively more likely to use CM. The median duration between newly diagnosed TB and the first CM consultation was 1068&#x02009;days (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographic characteristics of the patients with tuberculosis in Taiwan</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Variable</th><th colspan="2">Non-CM users</th><th colspan="2">CM users<sup>&#x02020;</sup></th><th rowspan="3"><italic>P</italic>-value</th></tr><tr><th colspan="2">n&#x02009;=&#x02009;1874 (44.753%)</th><th colspan="2">n&#x02009;=&#x02009;2051 (52.25%)</th></tr><tr><th>n</th><th>%</th><th>n</th><th>%</th></tr></thead><tbody><tr><td>Sex</td><td/><td/><td/><td/><td>&#x0003c;.0001*</td></tr><tr><td>&#x02003;Female</td><td>354</td><td>18.89</td><td>861</td><td>41.98</td><td/></tr><tr><td>&#x02003;Male</td><td>1520</td><td>81.11</td><td>1190</td><td>58.02</td><td/></tr><tr><td>Age at baseline (year)</td><td/><td/><td/><td/><td>&#x0003c;.0001*</td></tr><tr><td>&#x02003;18&#x02013;29</td><td>100</td><td>5.34</td><td>293</td><td>14.29</td><td/></tr><tr><td>&#x02003;30&#x02013;39</td><td>127</td><td>6.78</td><td>242</td><td>11.8</td><td/></tr><tr><td>&#x02003;&#x02009;&#x02265;&#x02009;40</td><td>1647</td><td>87.89</td><td>1516</td><td>73.92</td><td/></tr><tr><td>&#x02003;Mean (SD)</td><td colspan="2">64.06 (17.68)</td><td colspan="2">53.25 (18.03)</td><td>&#x0003c;.0001&#x02021;</td></tr><tr><td>Urbanization</td><td/><td/><td/><td/><td>&#x0003c;.0001*</td></tr><tr><td>&#x02003;1 (highest)</td><td>408</td><td>21.77</td><td>529</td><td>25.8</td><td/></tr><tr><td>&#x02003;2</td><td>431</td><td>23</td><td>607</td><td>29.61</td><td/></tr><tr><td>&#x02003;3</td><td>327</td><td>17.45</td><td>345</td><td>16.83</td><td/></tr><tr><td>&#x02003;4</td><td>354</td><td>18.89</td><td>306</td><td>14.93</td><td/></tr><tr><td>&#x02003;5+ (lowest)</td><td>354</td><td>18.89</td><td>263</td><td>12.83</td><td/></tr><tr><td colspan="6">Drug used</td></tr><tr><td>&#x02003;rifampin</td><td>1819</td><td>97.07</td><td>2005</td><td>97.76</td><td>0.1714*</td></tr><tr><td>&#x02003;ethambutol</td><td>1796</td><td>95.84</td><td>1985</td><td>96.78</td><td>0.116*</td></tr><tr><td>&#x02003;isoniazid</td><td>1802</td><td>96.16</td><td>1972</td><td>96.15</td><td>0.9874*</td></tr><tr><td>&#x02003;pyrazinamide</td><td>1581</td><td>84.36</td><td>1798</td><td>87.66</td><td>0.0028*</td></tr><tr><td>&#x02003;levofloxacin</td><td>456</td><td>24.33</td><td>536</td><td>26.13</td><td>0.1948*</td></tr><tr><td>&#x02003;streptomycin</td><td>131</td><td>6.99</td><td>113</td><td>5.51</td><td>0.055*</td></tr><tr><td>&#x02003;kanamycin</td><td>73</td><td>3.9</td><td>81</td><td>3.95</td><td>0.9308*</td></tr><tr><td>&#x02003;prothionamide</td><td>18</td><td>0.96</td><td>24</td><td>1.17</td><td>0.5237*</td></tr><tr><td>&#x02003;cyclosporine</td><td>2</td><td>0.11</td><td>5</td><td>0.24</td><td>0.456$</td></tr><tr><td>&#x02003;moxifloxacin</td><td>0</td><td>0</td><td>1</td><td>0.05</td><td>&#x02013;</td></tr><tr><td>Interval between the onset oftuberculosis and the first CM consultation, days(median)</td><td colspan="2"/><td colspan="2">1395 (1068)</td><td>&#x02013;</td></tr></tbody></table><table-wrap-foot><p>&#x02021; t-test; * chi-square; $ Fisher&#x02019;s exact test</p><p>Abbreviation: <italic>SD</italic> standard deviation, <italic>CM</italic> Chinese Medicine</p><p>&#x02020; CM users referred to patients with history of TB who had visited CM clinics and had CM outpatient clinical records of tuberculosis or respiratory diseases</p></table-wrap-foot></table-wrap></p><p id="Par20">Regarding the treatment modes employed among the CM users, approximately 95% of CM users (<italic>n</italic>&#x02009;=&#x02009;1944) received only Chinese medicines, 5.2% of patients received combined treatment with both Chinese medicines and acupuncture, and the remaining 0.2% of patients received only acupuncture treatments. Among all CM users (patients with a medical history of TB who had visited CM clinics and had CM outpatient clinical records of TB or respiratory diseases; <italic>n</italic>&#x02009;=&#x02009;2051), 90.15% visited CM clinics 1&#x02013;3 times annually, while 4.58% patients consulted CM doctors more than 6 times/year (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Distribution of CMs according to type of CM treatment received in patients with tuberculosis, stratified by the number of outpatient visits</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Number of CM visits (times/per year)</th><th>Only Chinese medicines</th><th>Only acupuncture</th><th>Combination of both treatments</th><th rowspan="2">Total <italic>n</italic>&#x02009;=&#x02009;2051 (100%)</th></tr><tr><th><italic>n</italic>&#x02009;=&#x02009;1944 (94.78%)</th><th><italic>n</italic>&#x02009;=&#x02009;4 (0.20%)</th><th><italic>n</italic>&#x02009;=&#x02009;103 (5.02%)</th></tr><tr><th>n (%)</th><th>n (%)</th><th>n (%)</th><th>n (%)</th></tr></thead><tbody><tr><td>1&#x02013;3</td><td char="(" align="char">1763 (90.69)</td><td>4 (100)</td><td char="(" align="char">82 (76.61)</td><td char="(" align="char">1849 (90.15)</td></tr><tr><td>4&#x02013;6</td><td char="(" align="char">96 (4.94)</td><td>0</td><td char="(" align="char">12 (11.65)</td><td char="(" align="char">108 (5.27)</td></tr><tr><td>&#x0003e;&#x02009;6</td><td char="(" align="char">85 (4.37)</td><td>0</td><td char="(" align="char">9 (8.74)</td><td char="(" align="char">94 (4.58)</td></tr></tbody></table><table-wrap-foot><p>Abbreviation: <italic>CM</italic> Chinese Medicine</p></table-wrap-foot></table-wrap></p><p id="Par21">The frequency distribution of disease categories related to respiratory discomforts and comorbidities that patients who had been diagnosed TB was analyzed (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Compared to the non-CM users, the frequencies of outpatient visits among TB patients who used CM were statistically higher across almost all discomforts and comorbidities, except swelling, mass, and lump in chest (Table <xref rid="Tab3" ref-type="table">3</xref>). More than 70% of TB patients used CM because of acute respiratory infections, cough, chronic obstructive pulmonary disease and allied conditions, and other diseases of upper respiratory tract. These results could indicate the comorbidities and complications of TB and may serve as an explanation for why TB patients complicated with long-term respiratory discomforts turn to CM doctors for help (Table <xref rid="Tab3" ref-type="table">3</xref>). We further investigated the prescription pattern of Chinese medicines and identified the ten most commonly prescribed formulas and single herbs. The ten most commonly prescribed single herbs and herbal formulas were analyzed and are listed in Tables&#x000a0;<xref rid="Tab4" ref-type="table">4</xref> and <xref rid="Tab5" ref-type="table">5</xref>, respectively. The most commonly prescribed herbal formulas and single herb were Xiao-Qing-Long-Tang, and Radix Platycodonis (Jie-Geng), respectively.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Frequency of different diseases related to symptoms of respiratory discomforts or complications in tuberculosis patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Disease (ICD-9-CM)</th><th colspan="2">Non-CM users</th><th colspan="2">CM users<sup>&#x02020;</sup></th><th rowspan="2"><italic>P</italic> value*</th></tr><tr><th>n</th><th>%</th><th>n</th><th>%</th></tr></thead><tbody><tr><td>Acute respiratory infections (460&#x02013;466)</td><td>1405</td><td>74.97</td><td>2022</td><td>98.59</td><td>&#x0003c;.0001</td></tr><tr><td>Other diseases of upper respiratory tract (470&#x02013;478)</td><td>564</td><td>30.1</td><td>1544</td><td>75.28</td><td>&#x0003c;.0001</td></tr><tr><td>Pneumonia and influenza (480&#x02013;488)</td><td>1156</td><td>61.69</td><td>1393</td><td>67.92</td><td>&#x0003c;.0001</td></tr><tr><td>Chronic obstructive pulmonary disease and allied conditions (490&#x02013;496)</td><td>1307</td><td>69.74</td><td>1663</td><td>81.08</td><td>&#x0003c;.0001</td></tr><tr><td>Pneumoconioses and other lung diseases due to external agents (500&#x02013;508)</td><td>183</td><td>9.77</td><td>146</td><td>7.12</td><td>0.0028</td></tr><tr><td>Other diseases of respiratory system (510&#x02013;519)</td><td>952</td><td>50.8</td><td>853</td><td>41.59</td><td>&#x0003c;.0001</td></tr><tr><td>Dyspnea and respiratory abnormalities (786.0)</td><td>313</td><td>16.7</td><td>488</td><td>23.79</td><td>&#x0003c;.0001</td></tr><tr><td>Stridor (786.1)</td><td>25</td><td>1.33</td><td>124</td><td>6.05</td><td>&#x0003c;.0001</td></tr><tr><td>Cough (786.2)</td><td>475</td><td>25.35</td><td>1519</td><td>74.06</td><td>&#x0003c;.0001</td></tr><tr><td>Hemoptysis (786.3)</td><td>211</td><td>11.26</td><td>375</td><td>18.28</td><td>&#x0003c;.0001</td></tr><tr><td>Abnormal sputum (786.4)</td><td>16</td><td>0.85</td><td>49</td><td>2.39</td><td>0.0002</td></tr><tr><td>Chest pain (786.5)</td><td>375</td><td>20.01</td><td>930</td><td>45.34</td><td>&#x0003c;.0001</td></tr><tr><td>Swelling, mass, or lump in chest (786.6)</td><td>32</td><td>1.71</td><td>50</td><td>2.44</td><td>0.1101</td></tr><tr><td>Hiccough (786.8)</td><td>9</td><td>0.48</td><td>40</td><td>1.95</td><td>&#x0003c;.0001</td></tr><tr><td>Other symptoms involving respiratory system and chest (786.9)</td><td>23</td><td>1.23</td><td>52</td><td>2.54</td><td>0.0028</td></tr></tbody></table><table-wrap-foot><p>* chi-square test</p><p>Abbreviation: SD standard deviation, <italic>CM</italic>, Chinese Medicine</p><p>&#x02020;CM users referred to patients with history of TB who had visited CM clinics and had CM outpatient clinical records of tuberculosis or respiratory diseases</p></table-wrap-foot></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption><p>Ten most commonly prescribed herbs for patients with tuberculosis</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Pin-yin name</th><th>Chinese Materia Medica name</th><th>Botanical name</th><th>Indication</th><th>Number of person-days</th></tr></thead><tbody><tr><td>Jie-Geng</td><td>Radix Platycodonis</td><td><italic>Platycodon grandiflorus</italic> (Jacq.) A.DC</td><td>Cough, large amount of sputum, sore throat</td><td>18,779</td></tr><tr><td>Bei-Mu</td><td>Bulbus Fritillariae Thunbergii</td><td><italic>Fritillaria thunbergii</italic> Miq.</td><td>Lung heat with thick phlegm, cough due to yin deficiency</td><td>18,460</td></tr><tr><td>Xing-Ren</td><td>Semen Armeniacae</td><td><italic>Prunus armeniaca</italic> L.var. <italic>ansu</italic> Max</td><td>Cough with phlegm, cough in older people or weaker bodies</td><td>14,610</td></tr><tr><td>Yu-Xing- Cao</td><td>Herba Houttuyniae</td><td><italic>Houttuynia cordata</italic> Thunb.</td><td>Fever, Inflammation of the respiratory tract</td><td>8978</td></tr><tr><td>Gua-Lou- Ren</td><td>Semen Trichosanthis</td><td><italic>Trichosanthes kirilowii</italic> Maxim</td><td>Hot cough with sticky phlegm</td><td>8905</td></tr><tr><td>Gan-Cao</td><td>Radix Glycyrrhizae</td><td><italic>Glycyrrhiza uralensis</italic> Fisch</td><td>Lung TB, cough with abundance of phlegm, tired and lack of strength, palpitation and short of breath</td><td>8054</td></tr><tr><td>Huang-Qin</td><td>Radix Scutellariae</td><td><italic>Scutellaria baicalensis</italic> Georgi</td><td>Cough due to heat syndromes, infection, and hemoptysis</td><td>7991</td></tr><tr><td>Mai-Men-Dong</td><td>Radix Ophiopogonis</td><td><italic>Ophiopogon japonicus</italic> (Thunb.) Ker Gawl.</td><td>Cough, weakness, consumption, short of breath, heat from yin deficiency</td><td>6934</td></tr><tr><td>Dan-Shen</td><td>Radix Salviae Miltiorrhizae</td><td><italic>Salvia miltiorrhiza</italic> Bge.</td><td>Restlessness, insomnia, irritability, blood deficiency and blood stasis</td><td>6508</td></tr><tr><td>Wu-Wei- Zi</td><td>Fructus Schisandrae</td><td><italic>Schisandra chinensis</italic> (Turcz.) Baill.</td><td>Wheezy cough, palpitations, and thirst due to yin deficiency</td><td>6154</td></tr></tbody></table></table-wrap><table-wrap id="Tab5"><label>Table 5</label><caption><p>Ten most commonly prescribed formulas for patients with tuberculosis</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Pin-yin name</th><th colspan="3">Constitutions</th><th rowspan="2">Indications in TCM</th><th rowspan="2">Number of person- days</th></tr><tr><th>Pin-yin name</th><th>Chinese Materia Medica name</th><th>Botanical name</th></tr></thead><tbody><tr><td rowspan="8">Xiao-Qing-Long-Tang</td><td>Ma-Huang</td><td>Herba Ephedrae</td><td><italic>Ephedra sinica</italic> Stapf.</td><td rowspan="8">Coughing and wheezing with copious, white, stringy sputum that is difficult to expectorate, stifling sensation in the chest, chronic water metabolism problems and thin mucus associated with weakness of lung</td><td rowspan="8">16,050</td></tr><tr><td>Gui-Zhi</td><td>Ramulus Cinnamomi</td><td><italic>Cinnamomum cassia</italic> Blume</td></tr><tr><td>Gan-Jiang</td><td>Rhizoma Zingiberis</td><td><italic>Zingiber officinale</italic> Rosc</td></tr><tr><td>Xi-Xin</td><td>Herba Asari</td><td><italic>Asarum heterotropoides</italic> F. Schmidt</td></tr><tr><td>Wu-Wei-Zi</td><td>Fructus Schisandrae</td><td><italic>Schisandra chinensis</italic> (Turcz.) Baill.</td></tr><tr><td>Bai-Shao</td><td>Radix Paeoniae Alba</td><td><italic>Paeonia lactiflora</italic> Pall.</td></tr><tr><td>Ban-Xia</td><td>Rhizoma Pinelliae</td><td><italic>Pinellia ternate</italic> (Thunb.) Makino</td></tr><tr><td>Gan-Cao</td><td>Radix Glycyrrhizae</td><td><italic>Glycyrrhiza uralensis</italic> Fisch</td></tr><tr><td rowspan="10">Xin-Yi-Qing-Fei-Tang</td><td>Xin-Yi</td><td>Magnoliae Flos</td><td><italic>Magnolia biondii</italic> Pamp.</td><td rowspan="10">Lung-heat cough with yellow phlegm, and accumulation of lung heat with nasal congestion</td><td rowspan="9">15,035</td></tr><tr><td>Huang-Qin</td><td>Radix Scutellariae</td><td><italic>Scutellaria baicalensis</italic> Georgi</td></tr><tr><td>Mai-Men-Dong</td><td>Radix Ophiopogonis</td><td><italic>Ophiopogon japonicus</italic> (Thunb.) Ker Gawl.</td></tr><tr><td>Zhi-Zi</td><td>Fructus Gardeniae</td><td><italic>Gardenia jasminoides</italic> J.Ellis</td></tr><tr><td>Shi- Gao</td><td>Gypsum fibrosum</td><td><italic>Hydrous Calcium</italic> Sulfate</td></tr><tr><td>Zhi-Mu</td><td>Rhizoma Anemarrhenae</td><td><italic>Anemarrhena asphodeloides</italic> Bunge</td></tr><tr><td>Sheng-Ma</td><td>Radix Cimicifugae</td><td><italic>Cimicifuga foetida</italic> L. var., intermedia, Regel</td></tr><tr><td>Bai-He</td><td>Bulbus Lilii</td><td><italic>Lilium brownii</italic> F. E. Br.ex Meillez</td></tr><tr><td>Pi-Pa-Ye</td><td>Folium Eriobotryae</td><td><italic>Eriobotrya japonica</italic> (Thunb) Lindl</td></tr><tr><td>Gan-Cao</td><td>Radix Glycyrrhizae</td><td><italic>Glycyrrhiza uralensis</italic> Fisch</td><td/></tr><tr><td rowspan="4">Ma-Xing-Gan-Shi-Tang</td><td>Ma-Huang</td><td>Herba Ephedrae</td><td><italic>Ephedra sinica</italic> Stapf.</td><td rowspan="4">Fever with thirst, wheezing, coughing, labored breathing caused by heat lodged in the lungs where it obstructs the flow of qi</td><td rowspan="4">14,185</td></tr><tr><td>Xing-Ren</td><td>Semen Armeniacae</td><td><italic>Prunus armeniaca</italic> L.var. <italic>ansu</italic> Maxim</td></tr><tr><td>Shi- Gao</td><td>Gypsum fibrosum</td><td><italic>Hydrous Calcium</italic> Sulfate</td></tr><tr><td>Gan-Cao</td><td>Radix Glycyrrhizae</td><td><italic>Glycyrrhiza uralensis</italic> Fisch</td></tr><tr><td rowspan="9">Ding-Chuan-Tang</td><td>Ma-Huang</td><td>Herba Ephedrae</td><td><italic>Ephedra sinica</italic> Stapf.</td><td rowspan="9">Coughing and wheezing with thick, yellow sputum that is difficult to expectorate. Fever and labored breathing caused by the disrupted flow of lung qi that transforms into heat</td><td rowspan="9">10,664</td></tr><tr><td>Xing-Ren</td><td>Semen Armeniacae</td><td><italic>Prunus armeniaca</italic> L.var. <italic>ansu</italic> Maxim</td></tr><tr><td>Ban-Xia</td><td>Rhizoma Pinelliae</td><td><italic>Pinellia ternate</italic> (Thunb.) Makino</td></tr><tr><td>Huang-Qin</td><td>Radix Scutellariae</td><td><italic>Scutellaria baicalensis</italic> Georgi</td></tr><tr><td>Sang-Bai-Pi</td><td>Cortex Mori</td><td><italic>Morus alba</italic> L.</td></tr><tr><td>Bai-Guo</td><td>Semen Ginkgo</td><td><italic>Ginkgo biloba</italic> L.</td></tr><tr><td>Su-Zi</td><td>Fructus Perillae</td><td><italic>Perilla frutescens</italic> (L.) Britton.</td></tr><tr><td>Kuan-Dong-Hua</td><td>Flos Farfarae</td><td><italic>Tussilago farfara</italic> L.</td></tr><tr><td>Gan-Cao</td><td>Radix Glycyrrhizae</td><td><italic>Glycyrrhiza uralensis</italic> Fisch</td></tr><tr><td rowspan="10">Yin-Qiao-San</td><td>Jin-Yin-Hua</td><td>Flos Lonicerae</td><td><italic>Lonicera japonica</italic> Thunb.</td><td rowspan="10">Fever, headache, thirst, cough with chills caused by warm pathogens or wind-heat entering the body and attacking the lungs</td><td rowspan="10">10,106</td></tr><tr><td>Lian-Qiao</td><td>Fructus Forsythiae</td><td><italic>Forsythia suspensa</italic> (Thunb.) Vahl</td></tr><tr><td>Jie-Geng</td><td>Radix Platycodonis</td><td><italic>Platycodon grandiflorus</italic> (Jacq.) A.DC.</td></tr><tr><td>Niu-Bang Zi</td><td>Fructus Arctii</td><td><italic>Arctium lappa</italic> L</td></tr><tr><td>Bo-He</td><td>Herba Menthae haplocalycis</td><td><italic>Mentha haplocalyx</italic> Briq</td></tr><tr><td>Dan-Dou- Chi</td><td>Semen Sojae preparatum</td><td><italic>Glycine max</italic> (L.) Merr.</td></tr><tr><td>Jing-Jie</td><td>Herba Schizonepetae</td><td><italic>Schizonepeta tenuifolia</italic> (Benth.)</td></tr><tr><td>Dan-Zhu-Ye</td><td>Herba Lophatheri</td><td><italic>Lophatherum gracile</italic> Brongn</td></tr><tr><td>Lu-Gen</td><td>Rhizoma Phragmitis recens</td><td><italic>Phragmites communis</italic> Trin</td></tr><tr><td>Gan-Cao</td><td>Radix Glycyrrhizae</td><td><italic>Glycyrrhiza uralensis</italic> Fisch</td></tr><tr><td rowspan="10">Bai-He-Gu Jin-Tang</td><td>Shu-Di-Huang</td><td>Radix Rehmanniae</td><td><italic>Rehmannia glutinosa</italic> Libosch</td><td rowspan="10">Coughing with blood-streaked sputum, wheezing, dry and sore throat, hot palms and soles, night sweats due to yin deficiency of lung and kidney with heat from yin deficiency</td><td rowspan="10">9735</td></tr><tr><td>Sheng-Di-Huang</td><td>Radix Rehmanniae</td><td><italic>Rehmannia glutinosa</italic> Libosch</td></tr><tr><td>Mai-Men-Dong</td><td>Radix Ophiopogonis</td><td><italic>Ophiopogon japonicus</italic> (Thunb.) Ker Gawl.</td></tr><tr><td>Bai-He</td><td>Bulbus Lilii</td><td><italic>Lilium brownii</italic> F. E. Br.ex Meillez</td></tr><tr><td>Bai-Shao</td><td>Radix Paeoniae Alba</td><td><italic>Paeonia lactiflora</italic> Pall</td></tr><tr><td>Dang-Gui</td><td>Radix Angelicae Sinensis</td><td><italic>Angelica sinensis</italic> (Oliv.) Diels</td></tr><tr><td>Bei-Mu</td><td>Bulbus Fritillariae Thunbergii</td><td><italic>Fritillaria thunbergii</italic> Miq.</td></tr><tr><td>Jie-Geng</td><td>Radix Platycodonis</td><td><italic>Platycodon grandiflorus</italic> (Jacq.) A.DC.</td></tr><tr><td>Xuan-Shen</td><td>Radix Scrophulariae</td><td><italic>Scrophularia ningpoensis</italic> Hemsl.</td></tr><tr><td>Gan-Cao</td><td>Radix Glycyrrhizae</td><td><italic>Glycyrrhiza uralensis</italic> Fisch</td></tr><tr><td rowspan="12">Xing-Su-Yin</td><td>Zi-Su</td><td>Folium Perillae</td><td><italic>Perilla frutescens</italic> (L.) Britton.</td><td rowspan="12">Wheezy cough, nasal congestion, low fever, headache due to a wind-cold pathogen attacking the lung</td><td rowspan="12">9343</td></tr><tr><td>Xing-Ren</td><td>Semen Armeniacae</td><td><italic>Prunus armeniaca</italic> L.var. <italic>ansu</italic> Maxim</td></tr><tr><td>Jie-Geng</td><td>Radix Platycodonis</td><td>P<italic>latycodon grandiflorus</italic> (Jacq.) A.DC.</td></tr><tr><td>Sang-Bai-Pi</td><td>Cortex Mori</td><td><italic>Morus alba</italic> L.</td></tr><tr><td>Huang-Qin</td><td>Radix Scutellariae</td><td><italic>Scutellaria baicalensis</italic> Georgi</td></tr><tr><td>Mai-Men-Dong</td><td>Radix Ophiopogonis</td><td><italic>Ophiopogon japonicus</italic> (Thunb.) Ker Gawl.</td></tr><tr><td>Bei-Mu</td><td>Bulbus Fritillariae Thunbergii</td><td><italic>Fritillaria thunbergii</italic> Miq.</td></tr><tr><td>Qian-Hu</td><td>Radix Peucedani</td><td><italic>Peucedanum decursivum</italic> Maxim</td></tr><tr><td>Sheng-Jiang</td><td>Rhizoma Zingiberis</td><td><italic>Zingiber officinale</italic> Rosc</td></tr><tr><td>Ju-Hong</td><td>Citri Reticulatae Pericarpium Rubrum</td><td><italic>Citrus maxima</italic> (Burm.) Merr.</td></tr><tr><td>Zhi-Ke</td><td>Fructus Citri Aurantii</td><td><italic>Citrus aurantium</italic> L.</td></tr><tr><td>Gan-Cao</td><td>Radix Glycyrrhizae</td><td><italic>Glycyrrhiza uralensis</italic> Fisch</td></tr><tr><td rowspan="7">Zhi-Sou-San</td><td>Jie-Geng</td><td>Radix Platycodonis</td><td><italic>Platycodon grandiflorus</italic> (Jacq.) A.DC.</td><td rowspan="7">Coughing with slight chills and fever, an itchy throat, phlegm that is difficult to expectorate that occurs in externally contracted wind cold</td><td rowspan="7">9275</td></tr><tr><td>Jing-Jie</td><td>Herba Schizonepetae</td><td><italic>Schizonepeta tenuifolia</italic> (Benth.)</td></tr><tr><td>Zi-Wan</td><td>Asteris Radix</td><td><italic>Aster tataricus</italic> L. f.</td></tr><tr><td>Bai-Bu</td><td>Radix stemonae</td><td><italic>Stemona sessilifolia</italic> (Miq.) Miq.</td></tr><tr><td>Bai-Qian</td><td>Rhizoma Cynanchi Stauntonii</td><td><italic>Cynanchum stauntonii</italic> (Decne.) Schltr.ex H.Lev.</td></tr><tr><td>Chen-Pi</td><td>Pericarpium Citri Reticulatae</td><td><italic>Citrus reticulate</italic> Blanco</td></tr><tr><td>Gan-Cao</td><td>Radix Glycyrrhizae</td><td><italic>Glycyrrhiza uralensis</italic> Fisch</td></tr><tr><td rowspan="4">Cang-Er-San</td><td>Cang-Er-Zi</td><td>Xanthii Fructus</td><td><italic>Xanthium Sibiricum</italic> Patr. ex Widder.</td><td rowspan="4">Nasal obstruction with purulent nasal discharge caused by an external wind pathogen obstructing the protective qi, which is governed by lung, dizziness, frontal headache</td><td rowspan="4">9248</td></tr><tr><td>Xin-Yi</td><td>Magnoliae Flos</td><td><italic>Magnolia biondii</italic> Pamp.</td></tr><tr><td>Bo-He</td><td>Herba Menthae haplocalycis</td><td><italic>Mentha haplocalyx</italic> Briq</td></tr><tr><td>Bai-Zhi</td><td>Radix Angelicae Dahuricae;</td><td><italic>Angelica dahurica</italic> (Hoffm.) Benth. &#x00026; Hook.f. ex Franch. &#x00026; Sav.</td></tr><tr><td rowspan="9">Qing-Zao-Jiu-Fei-Tang</td><td>Sang-Ye</td><td>Folium Mori</td><td><italic>Morus alba</italic> L.</td><td rowspan="9">Wheezing, cough, dry, parched throat, dry nasal passages, headache, fever, irritability, thirst due to invasion of external warm-dryness attacking the lungs and causing damage to the lung qi and yin</td><td rowspan="9">8795</td></tr><tr><td>Shi-Gao</td><td>Gypsum fibrosum</td><td><italic>Hydrous Calcium</italic> Sulfate</td></tr><tr><td>Gan-Cao</td><td>Radix Glycyrrhizae</td><td><italic>Glycyrrhiza uralensis</italic> Fisch</td></tr><tr><td>Xing-Ren</td><td>Semen Armeniacae</td><td><italic>Prunus armeniaca</italic> L.var. <italic>ansu</italic> Maxim</td></tr><tr><td>Mai-Men-Dong</td><td>Radix Ophiopogonis</td><td><italic>Ophiopogon japonicus</italic> (Thunb.) Ker Gawl.</td></tr><tr><td>Pi-Pa-Ye</td><td>Folium Eriobotryae</td><td><italic>Eriobotrya japonica</italic> (Thunb) Lindl</td></tr><tr><td>E-Jiao</td><td>Colla Corii Asini</td><td><italic>Equus asinus</italic> L.</td></tr><tr><td>Ren-Shen</td><td>Radix Ginseng</td><td><italic>Panax ginseng</italic> C. A. Mey</td></tr><tr><td>Hu-Ma-Ren</td><td>Semen Sesami Nigrum</td><td><italic>Sesamum indicum</italic> L.</td></tr></tbody></table></table-wrap></p><p id="Par22">We further conducted a network analysis and found that the core patterns of herbal formulas and herbs prescribed for TB patients consisted of Ma-Xing-Gan-Shi-Tang, Bulbus Fritillariae Thunbergii (Bei-Mu), Radix Platycodonis (Jie-Geng), and Semen Armeniacae (Xing-Ren) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). We further summarized these findings in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>.<fig id="Fig2"><label>Fig. 2</label><caption><p>The 100 most commonly prescribed herbal formulas and single herbs for patients with tuberculosis were assessed, and the core pattern of the prescriptions shows that Ma-Xing-Gan-Shi-Tang, Bei-Mu, Jie-Geng, and Xing-Ren were among the most frequently prescribed combinations</p></caption><graphic xlink:href="12906_2018_2377_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Summarized illustration of the core prescription pattern for patients with tuberculosis in Taiwan</p></caption><graphic xlink:href="12906_2018_2377_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec9"><title>Discussion</title><p id="Par23">In this study, we first observed that the median duration between newly diagnosed TB and the first CM consultation was 1068&#x02009;days. Many TB patients complicated with long-term respiratory discomforts sought CM services. We then determined that Ma-Xing-Gan-Shi-Tang, Bulbus Fritillariae Thunbergii (Bei-Mu), Radix Platycodonis (Jie-Geng), and Semen Armeniacae (Xing-Ren) were the core prescriptions for patients with TB in Taiwan. To the best of our knowledge, this report describes the first nationwide population-based cohort study investigating CM utilization patterns among TB patients complicated with long-term respiratory discomforts. However, whether CM combined with modern conventional medicine has beneficial effects or risks requires further investigation.</p><p id="Par24">The phenomenon that female patients with TB were relatively more likely to seek CM services is comparable to a previous Taiwanese survey demonstrating that women had a greater tendency to seek CM consultations [<xref ref-type="bibr" rid="CR34">34</xref>]. It has been reported that women are more susceptible to side effects from anti-TB drugs due to higher CYP3A activity [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], although men are more susceptible to TB than women [<xref ref-type="bibr" rid="CR36">36</xref>]. Women may exhibit more help-seeking behaviors than men and are more likely to seek complementary therapies when they suffer from chronic or catastrophic illness [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>].</p><p id="Par25">We also observed that younger patients (18&#x02013;39 y/o) and those who lived in more urbanized areas were relatively more likely to choose CM, in accordance with previous studies [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Patients younger than 40&#x02009;years old are likely to be more aware of alternative therapeutic choices. A previous report had shown that women, people with high socioeconomic status, higher education levels, self-perceived poor health status, and people who exercise regularly tend to visit CM services more often in Taiwan [<xref ref-type="bibr" rid="CR40">40</xref>]. Patients who reside in more urbanized areas usually have a higher socioeconomic status and fewer barriers to accessing medical services [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. The time and money spent on transportation may also lead to a significant inequality in contact with the health system [<xref ref-type="bibr" rid="CR43">43</xref>&#x02013;<xref ref-type="bibr" rid="CR45">45</xref>]. Therefore, people who live in urbanized areas have a greater tendency to use CM services.</p><p id="Par26">In Taiwan, patients with a diagnosis of TB are required to receive pharmacological therapy to control TB infection with monitoring by local health officers based on the government&#x02019;s health policy [<xref ref-type="bibr" rid="CR46">46</xref>]. The included patients who had been diagnosed with TB should have received standard anti-TB treatment. In Taiwan, recommended standard treatment for adult respiratory TB consists of a regimen of isoniazid, rifampicin, pyrazinamide, and ethambutol for 2&#x02009;months, followed by isoniazid, rifampicin, and ethambutol for 4&#x02009;months with monitoring by local health officers according to governmental policy [<xref ref-type="bibr" rid="CR46">46</xref>]. The total treatment course takes approximately 6&#x02009;months in newly diagnosed patients [<xref ref-type="bibr" rid="CR46">46</xref>]. The median duration between newly diagnosed TB and the first CM consultation was 1068&#x02009;days. During the follow-up period, patients might seek CM consultation due to symptoms of respiratory discomfort or complications. In addition to respiratory illness, they may also experience other symptoms related to the anti-TB treatment, such as skin rash or drug fever, GI intolerance, nausea, vomiting, visual toxicity, hearing disturbances and arthralgia [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR47">47</xref>&#x02013;<xref ref-type="bibr" rid="CR49">49</xref>]. The NHI insurance coverage for CM treatments may play a considerable role in patients&#x02019; tendency to seek CM consultations. Medical services in both Western medicine and CM have been promoted due to the high coverage of the NHI program. Furthermore, the cost of co-payment for concentrated scientific herbal granules is approximately $15&#x02009;U.S. dollars per month under the NHI Program in Taiwan. The tendency of patients to seek CM may continue to increase since the co-payment for Chinese medicines is relatively low [<xref ref-type="bibr" rid="CR50">50</xref>&#x02013;<xref ref-type="bibr" rid="CR53">53</xref>].</p><p id="Par27">Among patients with TB, most CM users (94.78%) received only Chinese medicines, which is consistent with previous studies investigating other respiratory diseases for which herbal products are frequently used as treatment in CM visits in Taiwan [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. In patients with adult-onset asthma, 76.7% patients who visited CM physicians received Chinese medicines [<xref ref-type="bibr" rid="CR54">54</xref>], and 97.1% of the CM-treated rhinosinusitis subjects were prescribed Chinese medicines [<xref ref-type="bibr" rid="CR52">52</xref>].</p><p id="Par28">Regarding the disease categories of the CM users identified in Table <xref rid="Tab3" ref-type="table">3</xref>, most of TB patients used CM because of acute respiratory infections, cough, chronic obstructive pulmonary disease and allied conditions, and other diseases of upper respiratory tract. It was reported that complications of TB include bacterial pneumonia, cor pulmonale, pneumothorax, and acute respiratory failure. Complications of TB could result in progression of functional pulmonary impairment and structural lung destructions [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. Patients with a prior TB diagnosis were more than twice as likely to have lung airflow obstruction [<xref ref-type="bibr" rid="CR56">56</xref>]. Furthermore, the complications of respiratory diseases can be independent predictor of shorter survival among patients with TB [<xref ref-type="bibr" rid="CR57">57</xref>]. TB patients might also turn to CM doctors in the hopes of relieving their symptoms and improving their health [<xref ref-type="bibr" rid="CR58">58</xref>].</p><p id="Par29">It must be noted that TB did not appear as a disease name in the records of the Chines medical literature. However, ancient people had observed the disease, and the symptoms and signs of TB and its related illness had been recorded and discussed in the Chinese medical literature. The prescriptions of CM were in accordance with the concepts of TB in CM, which were related to chronic cough with symptoms and signs of consumption or exhaustion. The prescriptions were prescribed after pattern identification and syndrome differentiation based on the theory of CM. Most of the prescriptions listed in Tables <xref rid="Tab4" ref-type="table">4</xref> and <xref rid="Tab5" ref-type="table">5</xref> are helpful for relieving symptoms caused by yin and qi deficiency of the lung with wind contraction, which corresponds to the respiratory symptoms related to long-term respiratory discomforts [<xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par30">Among the single herbs identified in the core prescriptions, the herb Bulbus Fritillariae Thunbergii has been commonly used as an antitussive agent [<xref ref-type="bibr" rid="CR59">59</xref>]. Its isosteroidal alkaloids have been reported to have tracheobronchial relaxant activity [<xref ref-type="bibr" rid="CR60">60</xref>]. Radix Platycodonis has been used for bronchitis, tonsillitis, and laryngitis in ancient times. The pharmacological constituent Platycodin D in Radix Platycodonis has demonstrated anti-inflammatory, antitumor [<xref ref-type="bibr" rid="CR61">61</xref>], antinociceptive and immunomodulatory activities. Immunostimulatory effects have been revealed via the suppression of IL-6 and TNF-&#x003b1; contents [<xref ref-type="bibr" rid="CR62">62</xref>] and enhancement of the killing activities of natural killer cells [<xref ref-type="bibr" rid="CR61">61</xref>]. Radix Platycodonis also inhibits OVA-induced airway inflammation and regulates the production and secretion of airway mucin [<xref ref-type="bibr" rid="CR63">63</xref>]. Furthermore, Radix Platycodonis has often served as an expectorant in diverse inflammatory pulmonary diseases [<xref ref-type="bibr" rid="CR64">64</xref>]. The other herb of the core prescriptions, Semen Armeniacae, has anti-inflammatory and analgesic effects by suppressing PGE2 and NO production [<xref ref-type="bibr" rid="CR65">65</xref>]. The amygdalin found in it has been used as an antitussive, anti-asthmatic, anticancer agent [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>].</p><p id="Par31">In addition to the above three herbs, other herbs have been reported to relieve respiratory symptoms or reduce inflammation. Herba Houttuyniae (Yu-Xing- Cao) has been reported to relieve fever, cough and asthma with anti-inflammatory [<xref ref-type="bibr" rid="CR68">68</xref>] and antiviral activities [<xref ref-type="bibr" rid="CR69">69</xref>]. This herb inhibits the production of pro-inflammatory cytokines via inhibition of the NF-&#x003ba;B signaling pathway in HMC-1 human mast cells [<xref ref-type="bibr" rid="CR70">70</xref>]. Semen Trichosanthis (Gua-Lou- Ren) has anti-inflammatory, and antibacterial activities [<xref ref-type="bibr" rid="CR71">71</xref>] and immunomodulatory effects [<xref ref-type="bibr" rid="CR72">72</xref>]. Ophiopogonin-D in Radix Ophiopogonis (Mai-Men-Dong) may be beneficial for reducing the excitability of parasympathetic ganglionic neurons in the airways and cholinergic control of airway function, and its antitussive effects might be due to the activation of K+ channels and hyperpolarization of paratracheal neurons [<xref ref-type="bibr" rid="CR73">73</xref>]. Radix Salviae Miltiorrhizae (Dan-Shen) could be helpful for reducing lung fibrosis [<xref ref-type="bibr" rid="CR74">74</xref>]. This species has been reported to exhibit anti-inflammatory and antioxidative effects [<xref ref-type="bibr" rid="CR75">75</xref>]. Radix Scutellariae (Huang-Qin) has shown pharmacological effects that are anti-inflammatory, antitumor and hepato-protective. Additionally, these extracts have antioxidant, antibacterial and antiviral effects [<xref ref-type="bibr" rid="CR76">76</xref>]. Research has indicated that a decoction containing Fructus Schisandrae (Wu-Wei-Zi) helps to prevent alveolitis and the development of pulmonary fibrosis [<xref ref-type="bibr" rid="CR77">77</xref>]. Liver-protective effects of Fructus Schisandrae via the inhibitory effect of CYP-3A4 activity have been reported [<xref ref-type="bibr" rid="CR78">78</xref>] and may also ameliorate the side effects of hepatitis resulting from the use of anti-TB medication.</p><p id="Par32">Among the herbal formulas identified in this research, Ma-Xing-Gan-Shi-Tang is one of the core prescriptions. It has been used to treat asthma [<xref ref-type="bibr" rid="CR79">79</xref>] and fever associated with pneumonia. It possesses anti-asthmatic, anti-pyretic, anti-inflammatory, and antitussive effects [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. Xiao-Qing-Long-Tang has anti-inflammatory, antiviral, and anti-allergy activities [<xref ref-type="bibr" rid="CR82">82</xref>], and it can reduce inflammation in lung tissue via an anti-apoptotic effect and inhibition of cytokine release, as well as prevent pulmonary fibrosis [<xref ref-type="bibr" rid="CR83">83</xref>&#x02013;<xref ref-type="bibr" rid="CR86">86</xref>]. Ding-Chuan-Tang has shown anti-asthmatic effects in clinical studies [<xref ref-type="bibr" rid="CR87">87</xref>]. Its protective effects against lung injury in asthma occurs by suppressing the production of pro-inflammatory cytokines with significantly reduced inflammatory cell infiltration, goblet cell proliferation, collagen deposition, and damage in the bronchi and alveoli [<xref ref-type="bibr" rid="CR88">88</xref>]. Xin-Yi-Qing-Fei-Tang has been commonly used for rhinitis [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>] and has been shown to reduce eosinophil, serum IgE and IL-4 levels [<xref ref-type="bibr" rid="CR89">89</xref>]. Clinical studies have reported that Yi-Qiao-San may be helpful for patients with H1N1 influenza to reduce the duration of fever [<xref ref-type="bibr" rid="CR90">90</xref>]. Lung cancer patients displayed better physical function, role function and cumulative survival after receiving combination treatments of a formula containing Bai-He-Gu Jin-Tang with Western medicine [<xref ref-type="bibr" rid="CR91">91</xref>].</p><p id="Par33">There are some limitations to our study. First, the herbal products purchased at the patients&#x02019; own expense in addition to the NHI program products were not included in this study. However, because the co-payment of herbal products through the NHI program was much less than the market cost, the possibility of purchasing herbs outside the NHI program was relatively low. In addition, compliance to prescription regimens was difficult to measure. Finally, this study focuses on the utilization of CM in patients with TB. In the future, a high-quality randomized controlled clinical trial with imaging data and species cultures to determine the efficacy of Chinese medicines for TB is expected.</p></sec><sec id="Sec10"><title>Conclusions</title><p id="Par34">Our study found that many TB patients complicated with long-term respiratory discomforts sought CM services in Taiwan. Those who were 18&#x02013;39 y/o, female, and who lived in urbanized areas tended to use CM. The prescription patterns identified in this study could be useful for future clinical studies or pharmacological investigations.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CM</term><def><p id="Par5">Chinese Medicine</p></def></def-item><def-item><term>ICD-9-CM</term><def><p id="Par6">International Classification of Diseases, Ninth Revision, Clinical Modification</p></def></def-item><def-item><term>NHI</term><def><p id="Par7">National Health Insurance</p></def></def-item><def-item><term>NHIRD</term><def><p id="Par8">National Health Insurance Research Database</p></def></def-item><def-item><term>TB</term><def><p id="Par9">Tuberculosis</p></def></def-item></def-list></glossary><ack><p>This study was based in part on data from the National Health Insurance Research Database, provided by the National Health Insurance Administration, Ministry of Health and Welfare, and managed by National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the National Health Insurance Administration, Ministry of Health and Welfare, or National Health Research Institutes.</p><sec id="FPar2"><title>Funding</title><p id="Par36">This work was financially supported by the Chinese Medicine Research Center, China Medical University, under the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (CMRC-CHM-2). This study was also supported in part by China Medical University Hospital (DMR-106-183&#x000a0;and&#x000a0;DMR-104-04) and the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW107-TDU-B-212-123004) and Health and the welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW107-TDU-B-212-114024), Taiwan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></sec><sec id="FPar3"><title>Availability of data and materials</title><p id="Par37">The datasets analyzed from NHIRD were provided by the National Health Insurance Administration and maintained by the National Health Research Institutes of Taiwan. The use of NHIRD is limited to research purposes only. Applicants must follow the Computer-Processed Personal Data Protection Law (<ext-link ext-link-type="uri" xlink:href="http://www.winklerpartners.com/?p=987">http://www.winklerpartners.com/?p=987</ext-link>) and related regulations of the National Health Insurance Administration and National Health Research Institutes.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>STY conceptualized the study. JHC performed the statistical analysis. STY, YRL, MYW, PSY and HRY contributed to the interpretation of the TCM data and pharmacological mechanisms. TCH contributed to the interpretation of Western medicine data. STY, YRL and HRY drafted the manuscript. STY and HRY finalized the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar1"><title>Ethics approval and consent to participate</title><p>This study followed the ethical standards of the responsible committee and with the Helsinki Declaration of 1964 and later versions. All the datasets were de-identified and encrypted before released by the National Health Research Institutes, Taiwan. All of the individuals or care providers could not be identified in the database. Patient consent was exempted for the total anonymity of all research data in this study. Therefore, the Research Ethics Committee of China Medical University and Hospital approved this study and waived the requirement for informed consent (CMUH104-REC2&#x02013;115).</p></sec><sec id="FPar4"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar5"><title>Competing interests</title><p>The authors declare that they have no conflicts of interest to disclose.</p></sec><sec id="FPar6"><title>Publisher&#x02019;s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zumla</surname><given-names>A</given-names></name><name><surname>George</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>V</given-names></name><name><surname>Herbert</surname><given-names>RH</given-names></name><name><surname>Oxley</surname><given-names>A</given-names></name><name><surname>Oliver</surname><given-names>M</given-names></name></person-group><article-title>The WHO 2014 global tuberculosis report--further to go</article-title><source>Lancet Glob Health</source><year>2015</year><volume>3</volume><issue>1</issue><fpage>e10</fpage><lpage>e12</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(14)70361-4</pub-id><pub-id pub-id-type="pmid">25539957</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group><person-group person-group-type="editor"><collab>Organization WH</collab></person-group><article-title>WHO Global tuberculosis report</article-title><source>In</source><year>2014</year><publisher-loc>Switzerland</publisher-loc><publisher-name>Geneva</publisher-name></element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Centers for Disease Control MoHaW, R.O.C. (Taiwan): CDC Annu Rep 2013&#x02013;2014. In<italic>.</italic> Edited by Centers for Disease Control MoHaW. R.O.C. (Taiwan): Ministry of Health and Welfare, R.O.C.(Taiwan); 2014.</mixed-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>MC</given-names></name><name><surname>Shu</surname><given-names>CC</given-names></name><name><surname>Lim</surname><given-names>CS</given-names></name><name><surname>Wang</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>LN</given-names></name><name><surname>Chao</surname><given-names>KM</given-names></name></person-group><article-title>Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study</article-title><source>BMC Infect Dis</source><year>2013</year><volume>13</volume><fpage>194</fpage><pub-id pub-id-type="doi">10.1186/1471-2334-13-194</pub-id><pub-id pub-id-type="pmid">23631563</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>H</given-names></name><name><surname>Shih</surname><given-names>CJ</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Kuo</surname><given-names>SC</given-names></name><name><surname>Hsu</surname><given-names>YT</given-names></name><name><surname>Ou</surname><given-names>SM</given-names></name><name><surname>Shih</surname><given-names>YN</given-names></name><name><surname>Tarng</surname><given-names>DC</given-names></name><name><surname>Li</surname><given-names>SY</given-names></name><name><surname>Chen</surname><given-names>YT</given-names></name><etal/></person-group><article-title>Risk of tuberculosis among healthcare workers in an intermediate-burden country: a nationwide population study</article-title><source>J Inf Secur</source><year>2014</year><volume>69</volume><issue>6</issue><fpage>525</fpage><lpage>532</lpage></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cojutti</surname><given-names>P</given-names></name><name><surname>Duranti</surname><given-names>S</given-names></name><name><surname>Isola</surname><given-names>M</given-names></name><name><surname>Baraldo</surname><given-names>M</given-names></name><name><surname>Viale</surname><given-names>P</given-names></name><name><surname>Bassetti</surname><given-names>M</given-names></name><name><surname>Pea</surname><given-names>F</given-names></name></person-group><article-title>Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB?</article-title><source>J Antimicrob Chemother</source><year>2016</year><volume>71</volume><issue>5</issue><fpage>1323</fpage><lpage>1329</lpage><pub-id pub-id-type="doi">10.1093/jac/dkv490</pub-id><pub-id pub-id-type="pmid">26832752</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>CC</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>JY</given-names></name><name><surname>Yu</surname><given-names>CJ</given-names></name><name><surname>Lee</surname><given-names>LN</given-names></name></person-group><article-title>Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical Centre</article-title><source>Int J Tuberc Lung Dis</source><year>2013</year><volume>17</volume><issue>7</issue><fpage>934</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.5588/ijtld.12.0782</pub-id><pub-id pub-id-type="pmid">23743313</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saukkonen</surname><given-names>JJ</given-names></name><name><surname>Cohn</surname><given-names>DL</given-names></name><name><surname>Jasmer</surname><given-names>RM</given-names></name><name><surname>Schenker</surname><given-names>S</given-names></name><name><surname>Jereb</surname><given-names>JA</given-names></name><name><surname>Nolan</surname><given-names>CM</given-names></name><name><surname>Peloquin</surname><given-names>CA</given-names></name><name><surname>Gordin</surname><given-names>FM</given-names></name><name><surname>Nunes</surname><given-names>D</given-names></name><name><surname>Strader</surname><given-names>DB</given-names></name><etal/></person-group><article-title>An official ATS statement: hepatotoxicity of antituberculosis therapy</article-title><source>Am J Respir Crit Care Med</source><year>2006</year><volume>174</volume><issue>8</issue><fpage>935</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.1164/rccm.200510-1666ST</pub-id><pub-id pub-id-type="pmid">17021358</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname><given-names>AT</given-names></name><name><surname>Mendes</surname><given-names>M</given-names></name><name><surname>Freitas</surname><given-names>S</given-names></name><name><surname>Roxo</surname><given-names>PC</given-names></name></person-group><article-title>Incidence and risk factors of major toxicity associated to first-line antituberculosis drugs for latent and active tuberculosis during a period of 10 years</article-title><source>Rev Port Pneumol (2006)</source><year>2015</year><volume>21</volume><issue>3</issue><fpage>144</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">25926250</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramachandran</surname><given-names>G</given-names></name><name><surname>Swaminathan</surname><given-names>S</given-names></name></person-group><article-title>Safety and tolerability profile of second-line anti-tuberculosis medications</article-title><source>Drug Saf</source><year>2015</year><volume>38</volume><issue>3</issue><fpage>253</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1007/s40264-015-0267-y</pub-id><pub-id pub-id-type="pmid">25676682</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yee</surname><given-names>D</given-names></name><name><surname>Valiquette</surname><given-names>C</given-names></name><name><surname>Pelletier</surname><given-names>M</given-names></name><name><surname>Parisien</surname><given-names>I</given-names></name><name><surname>Rocher</surname><given-names>I</given-names></name><name><surname>Menzies</surname><given-names>D</given-names></name></person-group><article-title>Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>167</volume><issue>11</issue><fpage>1472</fpage><lpage>1477</lpage><pub-id pub-id-type="doi">10.1164/rccm.200206-626OC</pub-id><pub-id pub-id-type="pmid">12569078</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasipanodya</surname><given-names>JG</given-names></name><name><surname>McNabb</surname><given-names>SJ</given-names></name><name><surname>Hilsenrath</surname><given-names>P</given-names></name><name><surname>Bae</surname><given-names>S</given-names></name><name><surname>Lykens</surname><given-names>K</given-names></name><name><surname>Vecino</surname><given-names>E</given-names></name><name><surname>Munguia</surname><given-names>G</given-names></name><name><surname>Miller</surname><given-names>TL</given-names></name><name><surname>Drewyer</surname><given-names>G</given-names></name><name><surname>Weis</surname><given-names>SE</given-names></name></person-group><article-title>Pulmonary impairment after tuberculosis and its contribution to TB burden</article-title><source>BMC Public Health</source><year>2010</year><volume>10</volume><fpage>259</fpage><pub-id pub-id-type="doi">10.1186/1471-2458-10-259</pub-id><pub-id pub-id-type="pmid">20482835</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>M</given-names></name><name><surname>Reed</surname><given-names>C</given-names></name></person-group><article-title>Complications of tuberculosis</article-title><source>Curr Opin Infect Dis</source><year>2014</year><volume>27</volume><issue>5</issue><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1097/QCO.0000000000000090</pub-id><pub-id pub-id-type="pmid">25028786</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vecino</surname><given-names>M</given-names></name><name><surname>Pasipanodya</surname><given-names>JG</given-names></name><name><surname>Slocum</surname><given-names>P</given-names></name><name><surname>Bae</surname><given-names>S</given-names></name><name><surname>Munguia</surname><given-names>G</given-names></name><name><surname>Miller</surname><given-names>T</given-names></name><name><surname>Fernandez</surname><given-names>M</given-names></name><name><surname>Drewyer</surname><given-names>G</given-names></name><name><surname>Weis</surname><given-names>SE</given-names></name></person-group><article-title>Evidence for chronic lung impairment in patients treated for pulmonary tuberculosis</article-title><source>J Infect Public Health</source><year>2011</year><volume>4</volume><issue>5&#x02013;6</issue><fpage>244</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.jiph.2011.08.005</pub-id><pub-id pub-id-type="pmid">22118719</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falci</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Greenlee</surname><given-names>H</given-names></name></person-group><article-title>Multiple chronic conditions and use of complementary and alternative medicine among US adults: results from the 2012 National Health Interview Survey</article-title><source>Prev Chronic Dis</source><year>2016</year><volume>13</volume><fpage>E61</fpage><pub-id pub-id-type="doi">10.5888/pcd13.150501</pub-id><pub-id pub-id-type="pmid">27149072</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>TY</given-names></name><name><surname>Chou</surname><given-names>YJ</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Pu</surname><given-names>C</given-names></name><name><surname>Chou</surname><given-names>YJ</given-names></name><name><surname>Chou</surname><given-names>P</given-names></name></person-group><article-title>Exploring the role of multiple chronic conditions in traditional Chinese medicine use and three types of traditional Chinese medicine therapy among adults in Taiwan</article-title><source>J Altern Complement Med</source><year>2015</year><volume>21</volume><issue>6</issue><fpage>350</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1089/acm.2014.0227</pub-id><pub-id pub-id-type="pmid">25966281</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleischer</surname><given-names>T</given-names></name><name><surname>Chang</surname><given-names>TT</given-names></name><name><surname>Chiang</surname><given-names>JH</given-names></name><name><surname>Hsieh</surname><given-names>CY</given-names></name><name><surname>Sun</surname><given-names>MF</given-names></name><name><surname>Yen</surname><given-names>HR</given-names></name></person-group><article-title>Integration of Chinese herbal medicine therapy improves survival of patients with chronic lymphocytic leukemia: a Nationwide population-based cohort study</article-title><source>Medicine (Baltimore)</source><year>2016</year><volume>95</volume><issue>21</issue><fpage>e3788</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000003788</pub-id><pub-id pub-id-type="pmid">27227953</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>A</given-names></name><name><surname>Komesaroff</surname><given-names>PA</given-names></name><name><surname>O'Brien</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Bensoussan</surname><given-names>A</given-names></name></person-group><article-title>Chinese medicine in Australia</article-title><source>J Altern Complement Med</source><year>2016</year><volume>22</volume><issue>7</issue><fpage>515</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1089/acm.2015.0260</pub-id><pub-id pub-id-type="pmid">27219354</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">WHO: WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region In<italic>.</italic> The LibraryWorld Health Organization Regional Office for the Western PacificP.O. Box 2932 United Nations Ave. cor. Taft Ave. 1000 Manila, Philippines: WHO Regional Office for the Western Pacific; 2007: 356.</mixed-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>LC</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Chou</surname><given-names>YJ</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Kao</surname><given-names>FY</given-names></name><name><surname>Huang</surname><given-names>YT</given-names></name></person-group><article-title>Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003</article-title><source>BMC Health Serv Res</source><year>2008</year><volume>8</volume><fpage>170</fpage><pub-id pub-id-type="doi">10.1186/1472-6963-8-170</pub-id><pub-id pub-id-type="pmid">18691428</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>HY</given-names></name><name><surname>Lin</surname><given-names>YH</given-names></name><name><surname>Su</surname><given-names>IH</given-names></name><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Yang</surname><given-names>SH</given-names></name><name><surname>Chen</surname><given-names>JL</given-names></name></person-group><article-title>Investigation on Chinese herbal medicine for primary dysmenorrhea: implication from a nationwide prescription database in Taiwan</article-title><source>Complement Ther Med</source><year>2014</year><volume>22</volume><issue>1</issue><fpage>116</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.ctim.2013.11.012</pub-id><pub-id pub-id-type="pmid">24559826</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">The Regulations of TCM Materials [<ext-link ext-link-type="uri" xlink:href="http://www.mohw.gov.tw/cp-3701-38847-2.html">http://www.mohw.gov.tw/cp-3701-38847-2.html</ext-link>].</mixed-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Guan</surname><given-names>X</given-names></name><name><surname>Chi</surname><given-names>Y</given-names></name><name><surname>Robinson</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>JP</given-names></name></person-group><article-title>Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): a systematic review of randomised clinical trials</article-title><source>Tuberculosis (Edinb)</source><year>2015</year><volume>95</volume><issue>4</issue><fpage>364</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1016/j.tube.2015.03.003</pub-id><pub-id pub-id-type="pmid">25861717</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>TT</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wei</surname><given-names>LL</given-names></name><name><surname>Yu</surname><given-names>XM</given-names></name><name><surname>Shi</surname><given-names>LY</given-names></name><name><surname>Xu</surname><given-names>DD</given-names></name><name><surname>Chen</surname><given-names>ZL</given-names></name><name><surname>Ping</surname><given-names>ZP</given-names></name><name><surname>Li</surname><given-names>JC</given-names></name></person-group><article-title>Serum protein gamma-glutamyl hydrolase, Ig gamma-3 chain C region, and haptoglobin are associated with the syndromes of pulmonary tuberculosis in traditional Chinese medicine</article-title><source>BMC Complement Altern Med</source><year>2015</year><volume>15</volume><fpage>243</fpage><pub-id pub-id-type="doi">10.1186/s12906-015-0686-4</pub-id><pub-id pub-id-type="pmid">26198726</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>R</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>CP</given-names></name></person-group><article-title>Effect of Chinese herbal medicine extracts on cell-mediated immunity in a rat model of tuberculosis induced by multiple drug-resistant bacilli</article-title><source>Mol Med Rep</source><year>2013</year><volume>8</volume><issue>1</issue><fpage>227</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.3892/mmr.2013.1491</pub-id><pub-id pub-id-type="pmid">23716296</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Office of Information Services, Executive Yuan: The Republic of China (Taiwan) - Yearbook 2012. Taiwan, R.O.C.: Executive Yuan, Taiwan; 2012.</mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Welfare MoHa: statistical indicators of Health and Welfare. In<italic>.</italic><ext-link ext-link-type="uri" xlink:href="https://dep.mohw.gov.tw/DOS/lp-2158-113.html">https://dep.mohw.gov.tw/DOS/lp-2158-113.html</ext-link>: Statistics Department, Ministry of Health and Welfare; 2015.</mixed-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>TP</given-names></name><name><surname>Liu</surname><given-names>PH</given-names></name><name><surname>Lien</surname><given-names>AS</given-names></name><name><surname>Yang</surname><given-names>SL</given-names></name><name><surname>Chang</surname><given-names>HH</given-names></name><name><surname>Yen</surname><given-names>HR</given-names></name></person-group><article-title>A nationwide population-based study of traditional Chinese medicine usage in children in Taiwan</article-title><source>Complement Ther Med</source><year>2014</year><volume>22</volume><issue>3</issue><fpage>500</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1016/j.ctim.2014.04.002</pub-id><pub-id pub-id-type="pmid">24906590</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C-Y</given-names></name><name><surname>Hung</surname><given-names>Y</given-names></name><name><surname>Chuang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Weng</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>K</given-names></name></person-group><article-title>Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey</article-title><source>J Health Manag</source><year>2006</year><volume>4</volume><issue>1</issue><fpage>1</fpage><lpage>22</lpage></element-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">Bensky D, Clavey S, Stoger E: Chinese herbal medicine: Materia Medica 3rd Ed. edn. Seatle, WA, U.S.a.: Eastland press, Inc.; 2004.</mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Scheid V, Bensky D, Ellis A, Barolet R. Chinese herbal medicine: formulas &#x00026; strategies. Eastland press; 2009.</mixed-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>K</given-names></name><name><surname>Shaw</surname><given-names>D</given-names></name><name><surname>Simmonds</surname><given-names>MS</given-names></name><name><surname>Leon</surname><given-names>CJ</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Lu</surname><given-names>A</given-names></name><name><surname>Sutherland</surname><given-names>I</given-names></name><name><surname>Ignatova</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>YP</given-names></name><name><surname>Verpoorte</surname><given-names>R</given-names></name><etal/></person-group><article-title>Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica</article-title><source>J Ethnopharmacol</source><year>2012</year><volume>140</volume><issue>3</issue><fpage>469</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.01.038</pub-id><pub-id pub-id-type="pmid">22330011</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CM</given-names></name><name><surname>Chu</surname><given-names>HT</given-names></name><name><surname>Wei</surname><given-names>YH</given-names></name><name><surname>Chen</surname><given-names>FP</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>PC</given-names></name><name><surname>Yen</surname><given-names>HR</given-names></name><name><surname>Chen</surname><given-names>TJ</given-names></name><name><surname>Chang</surname><given-names>HH</given-names></name></person-group><article-title>The Core pattern analysis on Chinese herbal medicine for Sjogren's syndrome: a Nationwide population-based study</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>9541</fpage><pub-id pub-id-type="doi">10.1038/srep09541</pub-id><pub-id pub-id-type="pmid">25923413</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>CC</given-names></name><name><surname>Liao</surname><given-names>CC</given-names></name><name><surname>Su</surname><given-names>YC</given-names></name><name><surname>Tsai</surname><given-names>CC</given-names></name><name><surname>Lin</surname><given-names>JG</given-names></name></person-group><article-title>Gender differences in traditional Chinese medicine use among adults in Taiwan</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><issue>4</issue><fpage>e32540</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0032540</pub-id><pub-id pub-id-type="pmid">22539941</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tostmann</surname><given-names>A</given-names></name><name><surname>Boeree</surname><given-names>MJ</given-names></name><name><surname>Aarnoutse</surname><given-names>RE</given-names></name><name><surname>de Lange</surname><given-names>WC</given-names></name><name><surname>van der Ven</surname><given-names>AJ</given-names></name><name><surname>Dekhuijzen</surname><given-names>R</given-names></name></person-group><article-title>Antituberculosis drug-induced hepatotoxicity: concise up-to-date review</article-title><source>J Gastroenterol Hepatol</source><year>2008</year><volume>23</volume><issue>2</issue><fpage>192</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1746.2007.05207.x</pub-id><pub-id pub-id-type="pmid">17995946</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhines</surname><given-names>AS</given-names></name></person-group><article-title>The role of sex differences in the prevalence and transmission of tuberculosis</article-title><source>Tuberculosis (Edinb)</source><year>2013</year><volume>93</volume><issue>1</issue><fpage>104</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.tube.2012.10.012</pub-id><pub-id pub-id-type="pmid">23219235</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>YT</given-names></name><name><surname>Chang</surname><given-names>TT</given-names></name><name><surname>Muo</surname><given-names>CH</given-names></name><name><surname>Wu</surname><given-names>MY</given-names></name><name><surname>Sun</surname><given-names>MF</given-names></name><name><surname>Yeh</surname><given-names>CC</given-names></name><name><surname>Yen</surname><given-names>HR</given-names></name></person-group><article-title>Use of complementary traditional Chinese medicines by adult Cancer patients in Taiwan: a Nationwide population-based study</article-title><source>Integr Cancer Ther</source><year>2018</year><volume>17</volume><issue>2</issue><fpage>531</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1177/1534735417716302</pub-id><pub-id pub-id-type="pmid">28665160</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>MC</given-names></name><name><surname>Pai</surname><given-names>FT</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Chang</surname><given-names>CM</given-names></name><name><surname>Chang</surname><given-names>HH</given-names></name><name><surname>Lee</surname><given-names>YC</given-names></name><name><surname>Sun</surname><given-names>MF</given-names></name><name><surname>Yen</surname><given-names>HR</given-names></name></person-group><article-title>Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: a nationwide population-based study</article-title><source>J Ethnopharmacol</source><year>2015</year><volume>176</volume><fpage>9</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.10.024</pub-id><pub-id pub-id-type="pmid">26481605</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>YR</given-names></name><name><surname>Wu</surname><given-names>MY</given-names></name><name><surname>Chiang</surname><given-names>JH</given-names></name><name><surname>Yen</surname><given-names>HR</given-names></name><name><surname>Yang</surname><given-names>ST</given-names></name></person-group><article-title>The utilization of traditional Chinese medicine in patients with dysfunctional uterine bleeding in Taiwan: a nationwide population-based study</article-title><source>BMC Complement Altern Med</source><year>2017</year><volume>17</volume><issue>1</issue><fpage>427</fpage><pub-id pub-id-type="doi">10.1186/s12906-017-1939-1</pub-id><pub-id pub-id-type="pmid">28851349</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name></person-group><article-title>Chinese medicine usage in Taiwan: a nationwide population-based study</article-title><source>RCHM J</source><year>2013</year><volume>10</volume><fpage>21</fpage><lpage>27</lpage></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>YJ</given-names></name><name><surname>Tian</surname><given-names>WH</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name></person-group><article-title>Urbanization and the utilization of outpatient services under National Health Insurance in Taiwan</article-title><source>Health Policy</source><year>2011</year><volume>103</volume><issue>2&#x02013;3</issue><fpage>236</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.healthpol.2011.08.007</pub-id><pub-id pub-id-type="pmid">21920621</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>SF</given-names></name><name><surname>Lew-Ting</surname><given-names>CY</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name><name><surname>Kuo</surname><given-names>KN</given-names></name></person-group><article-title>Insurance covered and non-covered complementary and alternative medicine utilisation among adults in Taiwan</article-title><source>Soc Sci Med</source><year>2008</year><volume>67</volume><issue>7</issue><fpage>1183</fpage><lpage>1189</lpage><pub-id pub-id-type="doi">10.1016/j.socscimed.2008.06.011</pub-id><pub-id pub-id-type="pmid">18649983</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duarte</surname><given-names>R</given-names></name><name><surname>Lonnroth</surname><given-names>K</given-names></name><name><surname>Carvalho</surname><given-names>C</given-names></name><name><surname>Lima</surname><given-names>F</given-names></name><name><surname>Carvalho</surname><given-names>ACC</given-names></name><name><surname>Munoz-Torrico</surname><given-names>M</given-names></name><name><surname>Centis</surname><given-names>R</given-names></name></person-group><article-title>Tuberculosis, social determinants and co-morbidities (including HIV)</article-title><source>Pulmonology</source><year>2018</year><volume>24</volume><issue>2</issue><fpage>115</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.rppnen.2017.11.003</pub-id><pub-id pub-id-type="pmid">29275968</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanimura</surname><given-names>T</given-names></name><name><surname>Jaramillo</surname><given-names>E</given-names></name><name><surname>Weil</surname><given-names>D</given-names></name><name><surname>Raviglione</surname><given-names>M</given-names></name><name><surname>Lonnroth</surname><given-names>K</given-names></name></person-group><article-title>Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review</article-title><source>Eur Respir J</source><year>2014</year><volume>43</volume><issue>6</issue><fpage>1763</fpage><lpage>1775</lpage><pub-id pub-id-type="doi">10.1183/09031936.00193413</pub-id><pub-id pub-id-type="pmid">24525439</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>M</given-names></name><name><surname>Oxlade</surname><given-names>O</given-names></name><name><surname>Lin</surname><given-names>HH</given-names></name></person-group><article-title>Modeling social, environmental and biological determinants of tuberculosis</article-title><source>Int J Tuberc Lung Dis</source><year>2011</year><volume>15</volume><issue>Suppl 2</issue><fpage>64</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.5588/ijtld.10.0535</pub-id><pub-id pub-id-type="pmid">21740661</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">Centers for Disease Control MoHaW, R.O.C. (Taiwan): Guidelines for diagnosis and treatment of tuberculosis 5E (in Chinese). In.; 2011: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov.tw/uploads/files/201803/81a3a893-a531-4092-b755-58665fe9074a.pdf">https://www.cdc.gov.tw/uploads/files/201803/81a3a893-a531-4092-b755-58665fe9074a.pdf</ext-link>. Accessed 201824 December 202017.</mixed-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nathanson</surname><given-names>E</given-names></name><name><surname>Gupta</surname><given-names>R</given-names></name><name><surname>Huamani</surname><given-names>P</given-names></name><name><surname>Leimane</surname><given-names>V</given-names></name><name><surname>Pasechnikov</surname><given-names>AD</given-names></name><name><surname>Tupasi</surname><given-names>TE</given-names></name><name><surname>Vink</surname><given-names>K</given-names></name><name><surname>Jaramillo</surname><given-names>E</given-names></name><name><surname>Espinal</surname><given-names>MA</given-names></name></person-group><article-title>Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-plus initiative</article-title><source>Int J Tuberc Lung Dis</source><year>2004</year><volume>8</volume><issue>11</issue><fpage>1382</fpage><lpage>1384</lpage><pub-id pub-id-type="pmid">15581210</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lienhardt</surname><given-names>C</given-names></name><name><surname>Cook</surname><given-names>SV</given-names></name><name><surname>Burgos</surname><given-names>M</given-names></name><name><surname>Yorke-Edwards</surname><given-names>V</given-names></name><name><surname>Rigouts</surname><given-names>L</given-names></name><name><surname>Anyo</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Jindani</surname><given-names>A</given-names></name><name><surname>Enarson</surname><given-names>DA</given-names></name><name><surname>Nunn</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the study C randomized controlled trial</article-title><source>JAMA</source><year>2011</year><volume>305</volume><issue>14</issue><fpage>1415</fpage><lpage>1423</lpage><pub-id pub-id-type="doi">10.1001/jama.2011.436</pub-id><pub-id pub-id-type="pmid">21486974</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forget</surname><given-names>EJ</given-names></name><name><surname>Menzies</surname><given-names>D</given-names></name></person-group><article-title>Adverse reactions to first-line antituberculosis drugs</article-title><source>Expert Opin Drug Saf</source><year>2006</year><volume>5</volume><issue>2</issue><fpage>231</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1517/14740338.5.2.231</pub-id><pub-id pub-id-type="pmid">16503745</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nahin</surname><given-names>RL</given-names></name><name><surname>Barnes</surname><given-names>PM</given-names></name><name><surname>Stussman</surname><given-names>BJ</given-names></name><name><surname>Bloom</surname><given-names>B</given-names></name></person-group><article-title>Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States</article-title><source>Natl Health Stat Report</source><year>2007</year><volume>2009</volume><issue>18</issue><fpage>1</fpage><lpage>14</lpage></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>HR</given-names></name><name><surname>Liang</surname><given-names>KL</given-names></name><name><surname>Huang</surname><given-names>TP</given-names></name><name><surname>Fan</surname><given-names>JY</given-names></name><name><surname>Chang</surname><given-names>TT</given-names></name><name><surname>Sun</surname><given-names>MF</given-names></name></person-group><article-title>Characteristics of traditional Chinese medicine use for children with allergic rhinitis: a nationwide population-based study</article-title><source>Int J Pediatr Otorhinolaryngol</source><year>2015</year><volume>79</volume><issue>4</issue><fpage>591</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1016/j.ijporl.2015.02.002</pub-id><pub-id pub-id-type="pmid">25704847</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>HR</given-names></name><name><surname>Sun</surname><given-names>MF</given-names></name><name><surname>Lin</surname><given-names>CL</given-names></name><name><surname>Sung</surname><given-names>FC</given-names></name><name><surname>Wang</surname><given-names>CC</given-names></name><name><surname>Liang</surname><given-names>KL</given-names></name></person-group><article-title>Adjunctive traditional Chinese medicine therapy for patients with chronic rhinosinusitis: a population-based study</article-title><source>Int Forum Allergy Rhinol</source><year>2015</year><volume>5</volume><issue>3</issue><fpage>240</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1002/alr.21446</pub-id><pub-id pub-id-type="pmid">25511322</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>CH</given-names></name><name><surname>Liu</surname><given-names>PH</given-names></name><name><surname>Van</surname><given-names>YH</given-names></name><name><surname>Lien</surname><given-names>AS</given-names></name><name><surname>Huang</surname><given-names>TP</given-names></name><name><surname>Yen</surname><given-names>HR</given-names></name></person-group><article-title>Traditional Chinese medicine for idiopathic precocious puberty: a hospital-based retrospective observational study</article-title><source>Complement Ther Med</source><year>2014</year><volume>22</volume><issue>2</issue><fpage>258</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.ctim.2014.01.002</pub-id><pub-id pub-id-type="pmid">24731897</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HM</given-names></name><name><surname>Lin</surname><given-names>SK</given-names></name><name><surname>Yeh</surname><given-names>CH</given-names></name><name><surname>Lai</surname><given-names>JN</given-names></name></person-group><article-title>Prescription pattern of Chinese herbal products for adult-onset asthma in Taiwan: a population-based study</article-title><source>Ann Allergy Asthma Immunol</source><year>2014</year><volume>112</volume><issue>5</issue><fpage>465</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1016/j.anai.2014.02.012</pub-id><pub-id pub-id-type="pmid">24656660</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>KP</given-names></name><name><surname>Chen</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Wu</surname><given-names>HD</given-names></name><name><surname>Wang</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>LN</given-names></name><name><surname>Yu</surname><given-names>CJ</given-names></name><name><surname>Yang</surname><given-names>PC</given-names></name><collab>Group T</collab></person-group><article-title>Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis</article-title><source>Clinics (Sao Paulo)</source><year>2011</year><volume>66</volume><issue>4</issue><fpage>549</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1590/S1807-59322011000400005</pub-id><pub-id pub-id-type="pmid">21655745</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menezes</surname><given-names>AM</given-names></name><name><surname>Hallal</surname><given-names>PC</given-names></name><name><surname>Perez-Padilla</surname><given-names>R</given-names></name><name><surname>Jardim</surname><given-names>JR</given-names></name><name><surname>Muino</surname><given-names>A</given-names></name><name><surname>Lopez</surname><given-names>MV</given-names></name><name><surname>Valdivia</surname><given-names>G</given-names></name><name><surname>Montes de Oca</surname><given-names>M</given-names></name><name><surname>Talamo</surname><given-names>C</given-names></name><name><surname>Pertuze</surname><given-names>J</given-names></name><etal/></person-group><article-title>Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America</article-title><source>Eur Respir J</source><year>2007</year><volume>30</volume><issue>6</issue><fpage>1180</fpage><lpage>1185</lpage><pub-id pub-id-type="doi">10.1183/09031936.00083507</pub-id><pub-id pub-id-type="pmid">17804445</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>YJ</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Chun</surname><given-names>EM</given-names></name><name><surname>Chang</surname><given-names>JH</given-names></name><name><surname>Shim</surname><given-names>SS</given-names></name></person-group><article-title>Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung</article-title><source>Int J Tuberc Lung Dis</source><year>2011</year><volume>15</volume><issue>2</issue><fpage>246</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">21219689</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>RH</given-names></name><name><surname>Xu</surname><given-names>HB</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name></person-group><article-title>Outcomes of Chinese herb medicine for the treatment of multidrug-resistant tuberculosis: a systematic review and meta-analysis</article-title><source>Complement Ther Med</source><year>2015</year><volume>23</volume><issue>4</issue><fpage>544</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/j.ctim.2015.06.006</pub-id><pub-id pub-id-type="pmid">26275647</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>SL</given-names></name><name><surname>Chan</surname><given-names>SW</given-names></name></person-group><article-title>Chromatographic analysis of Fritillaria isosteroidal alkaloids, the active ingredients of Beimu, the antitussive traditional Chinese medicinal herb</article-title><source>J Chromatogr A</source><year>2001</year><volume>935</volume><issue>1&#x02013;2</issue><fpage>321</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/S0021-9673(01)01258-4</pub-id><pub-id pub-id-type="pmid">11762784</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="other">Wu X, Chan SW, Ma J, Li P, Shaw PC, Lin G. Investigation of association of chemical profiles with the tracheobronchial relaxant activity of Chinese medicinal herb Beimu derived from various Fritillaria species. J Ethnopharmacol. 2017.</mixed-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>HX</given-names></name><name><surname>Li</surname><given-names>D</given-names></name></person-group><article-title>Platycodin d improves the immunogenicity of Newcastle disease virus-based recombinant avian influenza vaccine in mice</article-title><source>Chem Biodivers</source><year>2010</year><volume>7</volume><issue>3</issue><fpage>677</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1002/cbdv.200900183</pub-id><pub-id pub-id-type="pmid">20232336</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>OG</given-names></name><name><surname>Ku</surname><given-names>SK</given-names></name><name><surname>An</surname><given-names>HD</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name></person-group><article-title>The effects of Platycodin D, a Saponin purified from Platycodi Radix, on collagen-induced DBA/1J mouse rheumatoid arthritis</article-title><source>Evid Based Complement Alternat Med</source><year>2014</year><volume>2014</volume><fpage>954508</fpage><pub-id pub-id-type="doi">10.1155/2014/954508</pub-id><pub-id pub-id-type="pmid">24511322</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Hwang</surname><given-names>YP</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Jeong</surname><given-names>HG</given-names></name></person-group><article-title>Inhibitory effect of Platycodi Radix on ovalbumin-induced airway inflammation in a murine model of asthma</article-title><source>Food Chem Toxicol</source><year>2009</year><volume>47</volume><issue>6</issue><fpage>1272</fpage><lpage>1279</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2009.02.022</pub-id><pub-id pub-id-type="pmid">19264106</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>SK</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Hong</surname><given-names>JH</given-names></name><name><surname>Seok</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>CJ</given-names></name></person-group><article-title>Effects of the root of Platycodon grandiflorum on airway mucin hypersecretion in vivo and platycodin D(3) and deapi-platycodin on production and secretion of airway mucin in vitro</article-title><source>Phytomedicine</source><year>2014</year><volume>21</volume><issue>4</issue><fpage>529</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2013.10.004</pub-id><pub-id pub-id-type="pmid">24290472</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>HK</given-names></name><name><surname>Yang</surname><given-names>HY</given-names></name><name><surname>Lee</surname><given-names>TH</given-names></name><name><surname>Shin</surname><given-names>MC</given-names></name><name><surname>Lee</surname><given-names>MH</given-names></name><name><surname>Shin</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>CJ</given-names></name><name><surname>Kim</surname><given-names>OJ</given-names></name><name><surname>Hong</surname><given-names>SP</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name></person-group><article-title>Armeniacae semen extract suppresses lipopolysaccharide-induced expressions of cyclooxygenase [correction of cycloosygenase]-2 and inducible nitric oxide synthase in mouse BV2 microglial cells</article-title><source>Biol Pharm Bull</source><year>2005</year><volume>28</volume><issue>3</issue><fpage>449</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1248/bpb.28.449</pub-id><pub-id pub-id-type="pmid">15744067</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isoza</surname><given-names>T</given-names></name><name><surname>Matano</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Kosaka</surname><given-names>N</given-names></name><name><surname>Tani</surname><given-names>T</given-names></name></person-group><article-title>Quantitative determination of amygdalin epimers by cyclodextrin-modified micellar electrokinetic chromatography</article-title><source>J Chromatogr A</source><year>2001</year><volume>923</volume><issue>1&#x02013;2</issue><fpage>249</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/S0021-9673(01)00969-4</pub-id><pub-id pub-id-type="pmid">11510547</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>HY</given-names></name><name><surname>Chang</surname><given-names>HK</given-names></name><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>MH</given-names></name><name><surname>Shin</surname><given-names>MS</given-names></name><name><surname>Ham</surname><given-names>DH</given-names></name><name><surname>Park</surname><given-names>HK</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><etal/></person-group><article-title>Amygdalin suppresses lipopolysaccharide-induced expressions of cyclooxygenase-2 and inducible nitric oxide synthase in mouse BV2 microglial cells</article-title><source>Neurol Res</source><year>2007</year><volume>29</volume><issue>Suppl 1</issue><fpage>S59</fpage><lpage>S64</lpage><pub-id pub-id-type="doi">10.1179/016164107X172248</pub-id><pub-id pub-id-type="pmid">17359643</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>HM</given-names></name><name><surname>Liang</surname><given-names>YZ</given-names></name><name><surname>Yi</surname><given-names>LZ</given-names></name><name><surname>Wu</surname><given-names>XJ</given-names></name></person-group><article-title>Anti-inflammatory effect of Houttuynia cordata injection</article-title><source>J Ethnopharmacol</source><year>2006</year><volume>104</volume><issue>1&#x02013;2</issue><fpage>245</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.09.012</pub-id><pub-id pub-id-type="pmid">16213118</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiow</surname><given-names>KH</given-names></name><name><surname>Phoon</surname><given-names>MC</given-names></name><name><surname>Putti</surname><given-names>T</given-names></name><name><surname>Tan</surname><given-names>BK</given-names></name><name><surname>Chow</surname><given-names>VT</given-names></name></person-group><article-title>Evaluation of antiviral activities of Houttuynia cordata Thunb. Extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection</article-title><source>Asian Pac J Trop Med</source><year>2016</year><volume>9</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.apjtm.2015.12.002</pub-id><pub-id pub-id-type="pmid">26851778</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Seo</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>GJ</given-names></name><name><surname>Jeon</surname><given-names>CY</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Jang</surname><given-names>BH</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Shin</surname><given-names>YC</given-names></name><name><surname>Ko</surname><given-names>SG</given-names></name></person-group><article-title>Houttuynia cordata Thunb inhibits the production of pro-inflammatory cytokines through inhibition of the NFkappaB signaling pathway in HMC-1 human mast cells</article-title><source>Mol Med Rep</source><year>2013</year><volume>8</volume><issue>3</issue><fpage>731</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.3892/mmr.2013.1585</pub-id><pub-id pub-id-type="pmid">23846481</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minh</surname><given-names>CV</given-names></name><name><surname>Nhiem</surname><given-names>NX</given-names></name><name><surname>Yen</surname><given-names>HT</given-names></name><name><surname>Kiem</surname><given-names>PV</given-names></name><name><surname>Tai</surname><given-names>BH</given-names></name><name><surname>Le Tuan Anh</surname><given-names>H</given-names></name><name><surname>Hien</surname><given-names>TT</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name></person-group><article-title>Chemical constituents of Trichosanthes kirilowii and their cytotoxic activities</article-title><source>Arch Pharm Res</source><year>2015</year><volume>38</volume><issue>8</issue><fpage>1443</fpage><lpage>1448</lpage><pub-id pub-id-type="doi">10.1007/s12272-014-0490-6</pub-id><pub-id pub-id-type="pmid">25630793</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Xiong</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>F</given-names></name><name><surname>Jiang</surname><given-names>P</given-names></name><name><surname>Chu</surname><given-names>Y</given-names></name></person-group><article-title>Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAM</article-title><source>Cell Mol Immunol</source><year>2011</year><volume>8</volume><issue>4</issue><fpage>359</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1038/cmi.2011.12</pub-id><pub-id pub-id-type="pmid">21572449</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishibashi</surname><given-names>H</given-names></name><name><surname>Mochidome</surname><given-names>T</given-names></name><name><surname>Okai</surname><given-names>J</given-names></name><name><surname>Ichiki</surname><given-names>H</given-names></name><name><surname>Shimada</surname><given-names>H</given-names></name><name><surname>Takahama</surname><given-names>K</given-names></name></person-group><article-title>Activation of potassium conductance by ophiopogonin-D in acutely dissociated rat paratracheal neurones</article-title><source>Br J Pharmacol</source><year>2001</year><volume>132</volume><issue>2</issue><fpage>461</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0703818</pub-id><pub-id pub-id-type="pmid">11159695</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>DQ</given-names></name><name><surname>Tian</surname><given-names>YP</given-names></name><name><surname>Gao</surname><given-names>HB</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Meng</surname><given-names>ZH</given-names></name><name><surname>Tong</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>HW</given-names></name></person-group><article-title>Study the effects of Salvia miltiorrhiza monomer IH764-3 on the expression of matrix metalloproteinase in lungs of rats exposed to Paraquat (PQ)</article-title><source>Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi</source><year>2012</year><volume>30</volume><issue>5</issue><fpage>321</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">22804981</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Seo</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>EJ</given-names></name></person-group><article-title>Salvianolic acid B inhibits atherogenesis of vascular cells through induction of Nrf2-dependent heme oxygenase-1</article-title><source>Curr Med Chem</source><year>2014</year><volume>21</volume><issue>26</issue><fpage>3095</fpage><lpage>3106</lpage><pub-id pub-id-type="doi">10.2174/0929867321666140601195940</pub-id><pub-id pub-id-type="pmid">24934350</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Fan</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Jia</surname><given-names>Z</given-names></name></person-group><article-title>The genus Scutellaria an ethnopharmacological and phytochemical review</article-title><source>J Ethnopharmacol</source><year>2010</year><volume>128</volume><issue>2</issue><fpage>279</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.01.006</pub-id><pub-id pub-id-type="pmid">20064593</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>HQ</given-names></name><name><surname>Hhang</surname><given-names>JR</given-names></name><name><surname>Gao</surname><given-names>MC</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>SF</given-names></name><name><surname>Wang</surname><given-names>XH</given-names></name><name><surname>Meng</surname><given-names>FY</given-names></name><name><surname>Wang</surname><given-names>YP</given-names></name></person-group><article-title>Comparative study between Ephedra sinica Stapf and Fructus Schisandrae Chinensis on ET-1 and 6-keto-prostaglandin F1alpha in rats with idiopathic pulmonary fibrosis</article-title><source>Genet Mol Res</source><year>2014</year><volume>13</volume><issue>2</issue><fpage>3761</fpage><lpage>3771</lpage><pub-id pub-id-type="doi">10.4238/2014.May.13.3</pub-id><pub-id pub-id-type="pmid">24854661</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>CK</given-names></name><name><surname>Tse</surname><given-names>AK</given-names></name><name><surname>Yu</surname><given-names>ZL</given-names></name><name><surname>Zhu</surname><given-names>GY</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Fong</surname><given-names>DW</given-names></name></person-group><article-title>Inhibition of cytochrome P450 3A4 activity by schisandrol a and gomisin a isolated from Fructus Schisandrae chinensis</article-title><source>Phytomedicine</source><year>2010</year><volume>17</volume><issue>8&#x02013;9</issue><fpage>702</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2009.12.005</pub-id><pub-id pub-id-type="pmid">20089387</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>TP</given-names></name><name><surname>Liu</surname><given-names>PH</given-names></name><name><surname>Lien</surname><given-names>AS</given-names></name><name><surname>Yang</surname><given-names>SL</given-names></name><name><surname>Chang</surname><given-names>HH</given-names></name><name><surname>Yen</surname><given-names>HR</given-names></name></person-group><article-title>Characteristics of traditional Chinese medicine use in children with asthma: a nationwide population-based study</article-title><source>Allergy</source><year>2013</year><volume>68</volume><issue>12</issue><fpage>1610</fpage><lpage>1613</lpage><pub-id pub-id-type="doi">10.1111/all.12273</pub-id><pub-id pub-id-type="pmid">24117783</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kao</surname><given-names>ST</given-names></name><name><surname>Yeh</surname><given-names>TJ</given-names></name><name><surname>Hsieh</surname><given-names>CC</given-names></name><name><surname>Shiau</surname><given-names>HB</given-names></name><name><surname>Yeh</surname><given-names>FT</given-names></name><name><surname>Lin</surname><given-names>JG</given-names></name></person-group><article-title>The effects of ma-Xing-Gan-Shi-tang on respiratory resistance and airway leukocyte infiltration in asthmatic Guinea pigs</article-title><source>Immunopharmacol Immunotoxicol</source><year>2001</year><volume>23</volume><issue>3</issue><fpage>445</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1081/IPH-100107343</pub-id><pub-id pub-id-type="pmid">11694034</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Chang</surname><given-names>CW</given-names></name></person-group><article-title>Wu CR: antitussive, anti-pyretic and toxicological evaluation of ma-Xing-Gan-Shi-tang in rodents</article-title><source>BMC Complement Altern Med</source><year>2016</year><volume>16</volume><issue>1</issue><fpage>456</fpage><pub-id pub-id-type="doi">10.1186/s12906-016-1440-2</pub-id><pub-id pub-id-type="pmid">27832784</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>AK</given-names></name><name><surname>Mizuguchi</surname><given-names>H</given-names></name><name><surname>Kodama</surname><given-names>M</given-names></name><name><surname>Dev</surname><given-names>S</given-names></name><name><surname>Umehara</surname><given-names>H</given-names></name><name><surname>Kitamura</surname><given-names>Y</given-names></name><name><surname>Matsushita</surname><given-names>C</given-names></name><name><surname>Takeda</surname><given-names>N</given-names></name><name><surname>Fukui</surname><given-names>H</given-names></name></person-group><article-title>Sho-seiryu-to suppresses histamine signaling at the transcriptional level in TDI-sensitized nasal allergy model rats</article-title><source>Allergol Int</source><year>2009</year><volume>58</volume><issue>1</issue><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.2332/allergolint.O-07-526</pub-id><pub-id pub-id-type="pmid">19050374</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagai</surname><given-names>T</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><name><surname>Emori</surname><given-names>M</given-names></name><name><surname>Nunome</surname><given-names>SY</given-names></name><name><surname>Yabe</surname><given-names>T</given-names></name><name><surname>Takeda</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name></person-group><article-title>Anti-allergic activity of a Kampo (Japanese herbal) medicine "Sho-seiryu-to (Xiao-Qing-long-tang)" on airway inflammation in a mouse model</article-title><source>Int Immunopharmacol</source><year>2004</year><volume>4</volume><issue>10&#x02013;11</issue><fpage>1353</fpage><lpage>1365</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2004.05.021</pub-id><pub-id pub-id-type="pmid">15313433</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><mixed-citation publication-type="other">Nagai T, Nakao M, Shimizu Y, Kodera Y, Oh-Ishi M, Maeda T, Yamada H: Proteomic analysis of anti-inflammatory effects of a Kampo (Japanese herbal) medicine "Shoseiryuto (Xiao-Qing-long-tang)" on airway inflammation in a mouse model. Evid Based Complement Alternat Med 2011, 2011:604196.</mixed-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>SD</given-names></name><name><surname>Lin</surname><given-names>LJ</given-names></name><name><surname>Chen</surname><given-names>CL</given-names></name><name><surname>Lee</surname><given-names>SC</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Wang</surname><given-names>JY</given-names></name><name><surname>Kao</surname><given-names>ST</given-names></name></person-group><article-title>Xiao-Qing-long-tang attenuates allergic airway inflammation and remodeling in repetitive Dermatogoides pteronyssinus challenged chronic asthmatic mice model</article-title><source>J Ethnopharmacol</source><year>2012</year><volume>142</volume><issue>2</issue><fpage>531</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.05.033</pub-id><pub-id pub-id-type="pmid">22658987</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>CQ</given-names></name><name><surname>Sun</surname><given-names>PY</given-names></name><name><surname>Ding</surname><given-names>DZ</given-names></name><name><surname>Moriuchi</surname><given-names>H</given-names></name><name><surname>Ishitsuka</surname><given-names>Y</given-names></name><name><surname>Irikura</surname><given-names>M</given-names></name><name><surname>Irie</surname><given-names>T</given-names></name></person-group><article-title>The ethical Kampo formulation Sho-seiryu-to (TJ-19) prevents bleomycin-induced pulmonary fibrosis in rats</article-title><source>Biol Pharm Bull</source><year>2010</year><volume>33</volume><issue>8</issue><fpage>1438</fpage><lpage>1442</lpage><pub-id pub-id-type="doi">10.1248/bpb.33.1438</pub-id><pub-id pub-id-type="pmid">20686245</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>CK</given-names></name><name><surname>Kuo</surname><given-names>ML</given-names></name><name><surname>Shen</surname><given-names>JJ</given-names></name><name><surname>See</surname><given-names>LC</given-names></name><name><surname>Chang</surname><given-names>HH</given-names></name><name><surname>Huang</surname><given-names>JL</given-names></name></person-group><article-title>Ding Chuan tang, a Chinese herb decoction, could improve airway hyper-responsiveness in stabilized asthmatic children: a randomized, double-blind clinical trial</article-title><source>Pediatr Allergy Immunol</source><year>2006</year><volume>17</volume><issue>5</issue><fpage>316</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1111/j.1399-3038.2006.00406.x</pub-id><pub-id pub-id-type="pmid">16846448</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>WK</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Kim</surname><given-names>MH</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>HY</given-names></name><name><surname>Yeo</surname><given-names>Y</given-names></name><name><surname>Park</surname><given-names>YC</given-names></name></person-group><article-title>Effects of inhalable microparticles of Seonpyejeongcheon-tang in an asthma mouse model: - effects of microparticles of SJT</article-title><source>Aust J Pharm</source><year>2016</year><volume>19</volume><issue>4</issue><fpage>303</fpage><lpage>311</lpage></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minami</surname><given-names>M</given-names></name><name><surname>Konishi</surname><given-names>T</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Arai</surname><given-names>T</given-names></name><name><surname>Makino</surname><given-names>T</given-names></name></person-group><article-title>Effect of Shin'iseihaito on murine allergic reaction induced by nasal sensitization</article-title><source>J Tradit Complement Med</source><year>2016</year><volume>6</volume><issue>3</issue><fpage>252</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.jtcme.2015.06.001</pub-id><pub-id pub-id-type="pmid">27419089</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>QQ</given-names></name><name><surname>Zou</surname><given-names>ZQ</given-names></name><name><surname>Liang</surname><given-names>ZA</given-names></name><name><surname>Gu</surname><given-names>L</given-names></name><name><surname>Dong</surname><given-names>JP</given-names></name><name><surname>Liang</surname><given-names>LR</given-names></name><name><surname>Li</surname><given-names>XW</given-names></name><name><surname>Hu</surname><given-names>K</given-names></name><etal/></person-group><article-title>Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial</article-title><source>Ann Intern Med</source><year>2011</year><volume>155</volume><issue>4</issue><fpage>217</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-155-4-201108160-00005</pub-id><pub-id pub-id-type="pmid">21844547</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>WR</given-names></name><name><surname>Yang</surname><given-names>SH</given-names></name><name><surname>Yu</surname><given-names>CT</given-names></name><name><surname>Wang</surname><given-names>CC</given-names></name><name><surname>Huang</surname><given-names>ST</given-names></name><name><surname>Huang</surname><given-names>TH</given-names></name><name><surname>Chiang</surname><given-names>MC</given-names></name><name><surname>Chang</surname><given-names>YC</given-names></name></person-group><article-title>Long-term effectiveness of combined treatment with traditional Chinese medicine and Western medicine on the prognosis of patients with lung Cancer</article-title><source>J Altern Complement Med</source><year>2016</year><volume>22</volume><issue>3</issue><fpage>212</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1089/acm.2015.0214</pub-id><pub-id pub-id-type="pmid">26986673</pub-id></element-citation></ref></ref-list></back></article>